var title_f42_52_43840="Polyethylene glycol electrolyte solution and sulfate solution kit: Drug information";
var content_f42_52_43840=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Polyethylene glycol electrolyte solution and sulfate solution kit: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F16137803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Laxative, Osmotic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F16137847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Suclear&trade;: FDA approved January 2013; anticipated availability currently undetermined. Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F16137804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bowel cleansing prior to GI examination",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 88098 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-FBD0C7583D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43840=[""].join("\n");
var outline_f42_52_43840=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16137803\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16137847\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16137804\">",
"      Use",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/88098\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/88098|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_52_43841="Normal conduction system";
var content_f42_52_43841=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Normal conduction system",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the normal intraventricular conduction system (His-Purkinje system). The Bundle of His divides into the left bundle branch and right bundle branch. The left bundle branch divides into anterior, posterior, and, in some cases, median fascicles. RA, RV, LA, and LV refer to the right and left atria and ventricles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43841=[""].join("\n");
var outline_f42_52_43841=null;
var title_f42_52_43842="Dermatomal herpes zoster";
var content_f42_52_43842=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79886&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79886&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatomal herpes zoster",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 407px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Grouped vesicles on an erythematous base present in a dermatomal distribution on the upper back due to Herpes zoster. The lesions stop abruptly at the midline.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43842=[""].join("\n");
var outline_f42_52_43842=null;
var title_f42_52_43843="Avoiding infections in pregnancy";
var content_f42_52_43843=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/52/43843/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43843/contributors\" id=\"au4555\">",
"       Vanessa A Barss, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/52/43843/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43843/contributors\" id=\"se4723\">",
"       Charles J Lockwood, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/52/43843/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43843/contributors\" id=\"de8449\">",
"       Allyson Bloom, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/52/43843?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Like all adults and children, pregnant women are at risk for developing viral and bacterial infections. Infections are a particular concern during pregnancy since some infections are more severe in pregnant women or may harm the fetus or newborn. However, you can take steps to decrease the chance of developing a potentially harmful illness during pregnancy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      AVOIDING EXPOSURE TO INFECTIOUS DISEASES DURING PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     The following practices can help reduce the chance of exposure to infectious agents known to cause problems during pregnancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Hygiene",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pregnant women can get infections by person-to-person contact, such as kissing, sexual contact, and getting saliva or urine on their hands and then touching their eyes or the inside of their noses or mouths. Good hygiene practices, such as frequent hand washing and avoiding contact with another person's saliva through shared foods, drinks, or utensils, can lessen your chances of becoming infected with potentially harmful illnesses.",
"    </p>",
"    <p>",
"     Good hygiene is particularly important for pregnant women who have young children or work with them, as in day care centers or schools. Some potentially harmful infections, such as cytomegalovirus, are more prevalent in young children.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h3\">",
"      Hand washing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hand washing is an essential and very effective way to prevent the spread of infection. Hands should be wet with water and plain or antimicrobial soap and rubbed together for 15 to 30 seconds. Pay special attention to the fingernails, between the fingers, and the wrists. Rinse the hands thoroughly and dry with a single use towel.",
"    </p>",
"    <p>",
"     Alcohol-based hand rubs are a good alternative for disinfecting hands if a sink is not available. Spread hand rubs over the entire surface of hands, fingers, and wrists until dry. Hand rubs are available as a liquid or wipe in small, portable sizes that are easy to carry in a pocket or handbag. When a sink is available, visibly soiled hands should be washed with soap and water.",
"    </p>",
"    <p>",
"     Hands should be washed before and after preparing food and eating, after going to the bathroom, after changing a diaper or assisting a child with toileting, after wiping a young child&rsquo;s nose or drool, after handling garbage or dirty laundry, after touching animals or pets, after handling children&rsquo;s toys, and after gardening.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Food precautions",
"     </span>",
"     &nbsp;&mdash;&nbsp;Expert groups like the Food Safety and Inspection Services (",
"     <a class=\"external\" href=\"file://www.fsis.usda.gov/\">",
"      www.fsis.usda.gov",
"     </a>",
"     ) and the Centers for Disease Control and Prevention have guidelines for food safety",
"     <strong>",
"      for everyone, not just pregnant women",
"     </strong>",
"     . These food precautions are detailed in a separate topic. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/30/29156?source=see_link&amp;anchor=H15#H15\">",
"      \"Patient information: Food poisoning (food-borne illness) (Beyond the Basics)\", section on 'Food poisoning prevention'",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Insect borne illnesses",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pregnant women should take precautions that reduce the risk of acquiring mosquito-borne infections (eg, West Nile virus in the United States, malaria in some tropical countries). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/19/16690?source=see_link\">",
"      \"Patient information: West Nile virus infection (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Mosquito bites can be prevented through use of protective clothing, avoiding the outdoors when mosquitoes are most active (dawn and dusk), and use of DEET-based insect repellents. DEET is the most effective insect repellent currently available. Products with 10 to 35 percent DEET are adequate in most circumstances. Used as recommended, DEET has an excellent safety record. Pregnant and breastfeeding women can use DEET.",
"    </p>",
"    <p>",
"     Updated information regarding mosquito repellents is available from the CDC at",
"     <a class=\"external\" href=\"file://www.cdc.gov/ncidod/dvbid/westnile/RepellentUpdates.htm\">",
"      www.cdc.gov/ncidod/dvbid/westnile/RepellentUpdates.htm",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Sexually transmitted infections",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pregnant women should be aware that your risk of being infected with a sexually transmitted infection may increase if you have more than one sexual partner or if your partner has more than one sexual partner. Unless you are absolutely certain that your partner has no other sexual partners and is free of sexually transmitted infections, you should ask your partner to wear a condom to reduce the chance of getting a sexually transmitted infection. You should avoid having sex, even with a condom, if your partner has signs of a sexually transmitted infection, such as discharge from the penis, pain when urinating, or blisters or sores on the genital skin. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/3/36916?source=see_link\">",
"      \"Patient information: Genital herpes (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=see_link\">",
"      \"Patient information: Gonorrhea (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/14/24802?source=see_link\">",
"      \"Patient information: Chlamydia (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/60/4035?source=see_link\">",
"      \"Patient information: Genital warts in women (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Travel",
"     </span>",
"     &nbsp;&mdash;&nbsp;Avoiding travel to high risk locations is one way to minimize the chances of becoming infected with certain infectious diseases. In some parts of the world, polio, yellow fever, and malaria are still common. The possibility of acquiring a food- or water-borne infectious disease is also higher in some parts of the world. For example, unpasteurized cheese is more widely available in France than in the United States. Women who are planning international travel during pregnancy should consult with a travel clinic about the safety of the planned destination. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/2/16421?source=see_link\">",
"      \"Patient information: General travel advice (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Immunizations for family",
"     </span>",
"     &nbsp;&mdash;&nbsp;Children and other family household members should be up to date with their immunizations; this decreases a pregnant woman's risk of exposure to infections during pregnancy. Vaccine safety during pregnancy is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=see_link\">",
"      \"Patient information: Vaccination during pregnancy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Animal borne illnesses",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women who are pregnant or planning pregnancy should avoid contact with all rodents and should not change cat litter boxes, or should wear gloves and then wash their hands. Precautions about handling pets and laboratory animals should be discussed with a healthcare provider. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=see_link\">",
"      \"Patient information: Animal bites (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      INFECTIONS",
"     </span>",
"    </p>",
"    <p>",
"     Several infectious diseases can cause problems in pregnancy. Currently, these infections cannot be prevented with a vaccine. These infections are best avoided by practicing good hygiene and avoiding direct contact with infected individuals (although this may be difficult in some cases).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Parvovirus B19 (Fifth disease)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Parvovirus B19 infection, also known as \"fifth disease,\" is a common childhood viral infection. Since the infection is common during childhood, 40 to 60 percent of women are already immune by the time they become pregnant.",
"    </p>",
"    <p>",
"     In adults, parvovirus causes mild to severe symptoms, including joint pain, fatigue, and body aches. A rash may appear on the face, trunk, arms, and legs. The rash on the face can be intensely red as though the person had been slapped (this is called a \"slapped cheek\" appearance). The illness generally resolves without treatment.",
"    </p>",
"    <p>",
"     It is difficult to avoid contact with people who are infected with parvovirus because the infection is common in the community and an infected person is contagious before symptoms develop. Frequent hand washing and avoiding shared food, drinks, or utensils can help to prevent infection.",
"    </p>",
"    <p>",
"     If you are exposed to parvovirus during pregnancy and you have not been tested previously, a blood test for parvovirus is recommended. A positive test soon after exposure means that you had the infection in the past and are now immune, so the fetus is protected from infection. If blood testing is initially negative, it may be repeated three to four weeks later to confirm that you have not developed the infection. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/29/40408?source=see_link\">",
"      \"Parvovirus B19 infection during pregnancy\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Pregnant women who become infected with parvovirus are monitored closely for signs of complications. Rarely, parvovirus can cause a miscarriage, fetal anemia (low blood count), or fetal heart problems.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Cytomegalovirus infection (CMV)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cytomegalovirus (CMV) is a virus that is transmitted by sexual contact or close contact with an infected person's saliva, urine, or other body fluids. Being infected with CMV causes few or no problems in people with a healthy immune system. However, the virus can cause serious problems for infants of mothers who are infected with CMV during pregnancy. The risk of becoming infected with CMV for the first time is higher for pregnant women who live with young children or work in day care centers. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=see_link\">",
"      \"Cytomegalovirus infection in pregnancy\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Currently, there is no way to prevent CMV infection. Medications to treat CMV in newborns are currently being studied. Vaccines against CMV are also being tested, but are not yet available. Good hygiene practices, especially hand washing, are important to decrease the chances of developing CMV infection during pregnancy. Guidelines from the Centers for Disease Control and Prevention (CDC) are available at",
"     <a class=\"external\" href=\"file://www.cdc.gov/ncidod/diseases/cmv.htm\">",
"      www.cdc.gov/ncidod/diseases/cmv.htm",
"     </a>",
"     , and include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Practice good personal hygiene throughout pregnancy, especially hand washing with soap and water after touching diapers or saliva (particularly if the child is in day care). Do not share food, drink, or eating utensils. Wash your hands after changing diapers, feeding a young child, wiping a young child&rsquo;s nose or drool, or handling the toys of a young child.",
"      </li>",
"      <li>",
"       If you develop a low-grade fever, body aches, enlarged lymph nodes, sore throat, and fatigue while pregnant, see your doctor or nurse. You may be tested for CMV with a blood test.",
"      </li>",
"      <li>",
"       Pregnant women with CMV are not usually treated for the infection. Newborns are not usually treated for CMV unless there are complications. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36664?source=see_link&amp;anchor=H23#H23\">",
"        \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\", section on 'Neonates'",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       There is a low risk of passing CMV infection to a newborn from a mother with recent CMV infection. However, the benefits of breastfeeding outweigh the minimal risk of passing CMV through breastmilk. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/63/34805?source=see_link\">",
"        \"Patient information: Deciding to breastfeed (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Toxoplasmosis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Toxoplasmosis is a parasitic illness that usually causes no symptoms. However, toxoplasmosis can affect the fetus if a woman becomes infected during pregnancy. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=see_link\">",
"      \"Toxoplasmosis and pregnancy\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Pregnant women should avoid eating rare and uncooked meat, which can be a source of this parasite. &nbsp;House cats can also carry toxoplasmosis in their feces. Pregnant women should have someone else change the litter box or wear gloves and then wash their hands carefully afterwards. It is also important to wear gloves while gardening and to wash hands after working in the yard since the soil can be contaminated by cat feces.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Listeria",
"     </span>",
"     &nbsp;&mdash;&nbsp;Listeria is a bacterial infection that can cause fetal death, premature birth, or newborn infection. It can be passed from an infected mother to her fetus through the blood. Signs and symptoms of Listeria include fever, chills, and back pain; a nonspecific flu-like illness is the most common symptom. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/46/745?source=see_link\">",
"      \"Treatment, prognosis, and prevention of Listeria monocytogenes infection\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Most people who become infected with Listeria have eaten food that is contaminated. Contaminated foods do not appear rotten or spoiled and it is not possible to know, based upon appearance or smell, if a food is safe. For this reason, women who are pregnant are advised to avoid foods that could contain Listeria (see",
"     <a class=\"local\" href=\"#H5\">",
"      'Food precautions'",
"     </a>",
"     above).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      IMMUNIZATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Immunizations safety during pregnancy is discussed separately. Pregnant women should get a flu shot every year. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=see_link\">",
"      \"Patient information: Vaccination during pregnancy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      TREATMENT OF INFECTIONS DURING PREGNANCY",
"     </span>",
"    </p>",
"    <p>",
"     The safety and availability of treatment for infection in pregnant women depends upon the type of infection and risk of harm (from the treatment or the infection) to the woman and her fetus. Pregnant women and their families are advised to discuss any concerns about infections or treatments with a healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23443452\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/52/8003?source=see_link\">",
"      Patient information: Vaccines and pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/1/37907?source=see_link\">",
"      Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/5/13394?source=see_link\">",
"      Patient information: Erythema infectiosum (fifth disease) (The Basics )",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/47/3826?source=see_link\">",
"      Patient information: Malaria (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23443493\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/30/29156?source=see_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/19/16690?source=see_link\">",
"      Patient information: West Nile virus infection (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/3/36916?source=see_link\">",
"      Patient information: Genital herpes (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=see_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/14/24802?source=see_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/60/4035?source=see_link\">",
"      Patient information: Genital warts in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/2/16421?source=see_link\">",
"      Patient information: General travel advice (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=see_link\">",
"      Patient information: Vaccination during pregnancy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=see_link\">",
"      Patient information: Animal bites (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/63/34805?source=see_link\">",
"      Patient information: Deciding to breastfeed (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19354?source=see_link\">",
"      Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/44/1736?source=see_link\">",
"      Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43062?source=see_link\">",
"      Group B streptococcal infection in pregnant women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9621?source=see_link\">",
"      Group B streptococcus: Virulence factors and pathogenic mechanisms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32602?source=see_link\">",
"      Immunizations during pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=see_link\">",
"      Intraamniotic infection (chorioamnionitis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28041?source=see_link\">",
"      Overview of TORCH infections",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=see_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6087?source=see_link\">",
"      Rubella in pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/39/22137?source=see_link\">",
"      Toxoplasmosis and pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/46/745?source=see_link\">",
"      Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33225?source=see_link\">",
"      Varicella-zoster virus infection in pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/29/40408?source=see_link\">",
"      Parvovirus B19 infection during pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12634?source=see_link\">",
"      Cytomegalovirus infection in pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36664?source=see_link\">",
"      Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 311-3435",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov\">",
"      www.cdc.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Infectious Diseases Society of America",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.idsociety.org\">",
"      www.idsociety.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?42/52/43843/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 14, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/52/43843?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     American College of Obstetricians and Gynecologists. Immunization for Women. www.immunizationforwomen.org (Accessed on May 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43843/abstract/2\">",
"      Lazzarotto T, Guerra B, Gabrielli L, et al. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect 2011; 17:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43843/abstract/3\">",
"      Lamont RF, Sobel JD, Vaisbuch E, et al. Parvovirus B19 infection in human pregnancy. BJOG 2011; 118:175.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f42_52_43843=[""].join("\n");
var outline_f42_52_43843=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           AVOIDING EXPOSURE TO INFECTIOUS DISEASES DURING PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           INFECTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           IMMUNIZATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           TREATMENT OF INFECTIONS DURING PREGNANCY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f42_52_43844="Histology of a variola maculopapular lesion";
var content_f42_52_43844=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F59400&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F59400&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Histology of a variola maculopapular lesion (500x magnification)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The predominate layer in this particular image is the stratum spinosum and cells demonstrating \"ballooning degeneration\", which is the intracellular swelling that eventually will lead to cellular lysis. The coalescence of these ruptured cells leads to the formation of microvesicles. The outward growth of the maculopapular lesion is due to the formation of these microvesicles, which are filled with an infiltration of proteinaceous material, inflammatory cells, and cellular debris. Arrow points to a Guarnieri body.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: The Public Health Image Library, Centers for Disease Control and Prevention. Photo by Dr. RB Haraszti.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43844=[""].join("\n");
var outline_f42_52_43844=null;
var title_f42_52_43845="Central line IJ anatomy";
var content_f42_52_43845=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    External landmarks for the central venous catheter placement in the internal jugular vein",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     UpToDate acknowledges the invaluable assistance of the University of Massacusetts Medical School, Department of Anatomy and Department of Emergency Medicine, including Thomas Ellis, MD and Jean Marcelin, MD, for the photographs of central venous catheter placement.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43845=[""].join("\n");
var outline_f42_52_43845=null;
var title_f42_52_43846="Tracheal burn";
var content_f42_52_43846=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69632&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69632&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severe tracheal burn injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 532px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows tracheostomy tube and severe stenosis of the intrathoracic trachea. Computed tomographic scan shows marked narrowing of the intrathoracic trachea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43846=[""].join("\n");
var outline_f42_52_43846=null;
var title_f42_52_43847="Levetiracetam: Drug information";
var content_f42_52_43847=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Levetiracetam: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/38/35429?source=see_link\">",
"    see \"Levetiracetam: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/0/25608?source=see_link\">",
"    see \"Levetiracetam: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Keppra XR&reg;;",
"     </li>",
"     <li>",
"      Keppra&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Levetiracetam&reg;;",
"     </li>",
"     <li>",
"      Ava-Levetiracetam;",
"     </li>",
"     <li>",
"      CO Levetiracetam;",
"     </li>",
"     <li>",
"      Dom-Levetiracetam;",
"     </li>",
"     <li>",
"      Keppra&reg;;",
"     </li>",
"     <li>",
"      PHL-Levetiracetam;",
"     </li>",
"     <li>",
"      PMS-Levetiracetam;",
"     </li>",
"     <li>",
"      PRO-Levetiracetam",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F187668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticonvulsant, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F187644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     When switching from oral to I.V. formulations, the total daily dose should be the same.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Myoclonic seizures:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Immediate release: Initial: 500 mg twice daily; may increase every 2 weeks by 500 mg/dose to the recommended dose of 1500 mg twice daily. Efficacy of doses other than 3000 mg/day has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Initial: 500 mg twice daily; may increase every 2 weeks by 500 mg/dose to the recommended dose of 1500 mg twice daily. Efficacy of doses other than 3000 mg /day has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Partial onset seizures:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Immediate release: Initial: 500 mg twice daily; may increase every 2 weeks by 500 mg/dose to a maximum of 1500 mg twice daily. Doses &gt;3000 mg/day have been used in trials; however, there is no evidence of increased benefit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Extended release: Initial: 1000 mg once daily; may increase every 2 weeks by 1000 mg/day to a maximum of 3000 mg once daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V.: Initial: 500 mg twice daily; may increase every 2 weeks by 500 mg/dose to a maximum of 1500 mg twice daily. Doses &gt;3000 mg/day have been used in trials; however, there is no evidence of increased benefit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tonic-clonic seizures:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Immediate release: Initial: 500 mg twice daily; may increase every 2 weeks by 500 mg/dose to the recommended dose of 1500 mg twice daily. Efficacy of doses other than 3000 mg/day has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Initial: 500 mg twice daily; may increase every 2 weeks by 500 mg/dose to the recommended dose of 1500 mg twice daily. Efficacy of doses other than 3000 mg/day has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Loading dose (unlabeled):",
"     </b>",
"     Oral: Immediate release: Initial doses of 1500-2000 mg have been well-tolerated (Betts, 2000; Koubeissi, 2008), although the necessity of a loading dose has not been established",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Refractory status epilepticus (unlabeled use):",
"     </b>",
"     I.V.: 1000-3000 mg administered over 15 minutes (Meierkord, 2010); 2500 mg has been safely administered over 5 minutes in one report (Uges, 2009).",
"     <b>",
"      Note:",
"     </b>",
"     Levetiracetam has not been well studied in comparison to other agents routinely used in this setting.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F187656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/0/25608?source=see_link\">",
"      see \"Levetiracetam: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Use oral solution in children &le;20 kg; oral solution or immediate release tablets may be used in children &gt;20 kg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Myoclonic seizures:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Children &ge;16 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Partial onset seizures:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 1 to &lt;6 months: Immediate release: Initial: 7 mg/kg/dose twice daily; may increase every 2 weeks by 7 mg/kg/dose to a maximum of 21 mg/kg/dose twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 6 months to &lt;4 years: Immediate release: Initial: 10 mg/kg/dose twice daily; may increase every 2 weeks by 10 mg/kg/dose to a maximum of 25 mg/kg/dose twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 4 to &lt;16 years: Immediate release: Initial: 10 mg/kg/dose twice daily; may increase every 2 weeks by 10 mg/kg/dose to a maximum of 30 mg/kg/dose twice daily (maximum daily dose: 3000 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;16 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Children &ge;16 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tonic-clonic seizures:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 6 to &lt;16 years: Immediate release: Initial: 10 mg/kg/dose twice daily; may increase every 2 weeks by 10 mg/kg/dose to the recommended dose of 30 mg/kg twice daily. Efficacy of doses other than 60 mg/kg/day has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;16 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Children &ge;16 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F187645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F187646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Immediate release and I.V. formulations:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;80 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 500-1500 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     50-80 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 500-1000 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 250-750 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 250-500 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     End-stage renal disease (ESRD) requiring hemodialysis: 500-1000 mg every 24 hours; supplemental dose of 250-500 mg is recommended posthemodialysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peritoneal dialysis (PD): 500-1000 mg every 24 hours (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): 250-750 mg every 12 hours (Arnoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      Extended release tablets:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;80 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 1000-3000 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     50-80 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 1000-2000 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 500-1500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : 500-1000 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     End-stage renal disease (ESRD) requiring hemodialysis: Use of immediate release formulation is recommended",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F187647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     U.S. labeling: No dosage adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Canadian labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild-to-moderate impairment: No dosage adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe impairment: Reduce maintenance dose by 50% in patients who",
"     <b>",
"      also",
"     </b>",
"     have Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;60 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in sodium chloride 0.54%: 1500 mg (100 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in sodium chloride 0.75%: 1000 mg (100 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in sodium chloride 0.82%: 500 mg (100 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 100 mg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Keppra&reg;: 100 mg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: 100 mg/mL (5 mL, 118 mL [DSC], 472 mL, 473 mL, 480 mL, 500 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Keppra&reg;: 100 mg/mL (480 mL) [dye free; grape flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 250 mg, 500 mg, 750 mg, 1000 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Keppra&reg;: 250 mg, 500 mg, 750 mg, 1000 mg [scored; gluten free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral: 500 mg, 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Keppra XR&reg;: 500 mg, 750 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM152832.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM152832.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F187620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Infuse over 15 minutes",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Oral: May be administered without regard to meals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral solution: Should be administered with a calibrated measuring device (not a household teaspoon or tablespoon)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet (immediate release and extended release): Only administer as whole tablet; do not crush, break or chew.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F3269043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Stable in NS, LR, D",
"     <sub>",
"      5",
"     </sub>",
"     W",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F187618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive therapy in the treatment of partial onset, myoclonic, and/or primary generalized tonic-clonic seizures",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F187675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Keppra&reg; may be confused with Keflex&reg;, Keppra XR&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       LevETIRAcetam may be confused with levOCARNitine, levofloxacin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Potential for dispensing errors between Keppra&reg; and Kaletra&reg; (lopinavir/ritonavir)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F187666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Behavioral symptoms (agitation, aggression, anger, anxiety, apathy, depersonalization, depression, emotional lability, hostility, hyperkinesias, irritability, nervousness, neurosis and personality disorder: adults 5% to 13%; children 5% to 38%), somnolence (8% to 23%), headache (14%), hostility (2% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (15%), anorexia (3% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (9% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (6% to 14%), rhinitis (4% to 13%), cough (2% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Accidental injury (17%), infection (2% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Facial edema (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue (10%), nervousness (4% to 10%), dizziness (5% to 9%), personality disorder (8%), pain (6% to 7%), agitation (6%), irritability  (6% to 7%), emotional lability (2% to 6%), mood swings (5%), depression (3% to 5%), vertigo (3% to 5%), ataxia (3%), amnesia (2%), anxiety (2%), confusion (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Bruising (4%), pruritus (2%), rash (2%), skin discoloration (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (8%), nausea (5%), gastroenteritis (4%), constipation (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urine abnormality (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Leukocytes decreased (2% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Neck pain (2% to 8%), paresthesia (2%), reflexes increased (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctivitis (3%), diplopia (2%), amblyopia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Ear pain (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Albuminuria (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Influenza (5%), asthma (2%), sinusitis (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (3% to 8%), viral infection (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Alopecia, anemia, catatonia, hematocrit decreased, hemoglobin decreased, hepatic failure, hepatitis, leukopenia, LFTs abnormal, neutropenia, pancreatitis, pancytopenia (with bone marrow suppression), psychotic symptoms, red blood cells decreased, suicide attempt, suicide behavior, suicide ideation, thrombocytopenia, weight loss",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F187623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the U.S. manufacturer's labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Hypersensitivity to levetiracetam or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F187607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: Impaired coordination, weakness, dizziness, and somnolence may occur, most commonly during the first month of therapy; use caution when driving or operating heavy machinery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dermatologic reactions: Severe reactions, including toxic epidermal necrolysis and Stevens-Johnson syndrome, have been reported; onset usually within ~2 weeks of treatment initiation, but may be delayed (&gt;4 months); drug should be discontinued if there are any signs of a hypersensitivity reaction or unspecified rash.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: Although rare, decreases in red blood cell counts, hemoglobin, hematocrit, white blood cell counts and neutrophils have been observed. Cases of eosinophilia have also been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension: Isolated elevations in diastolic blood pressure measurements have been reported in children &lt;4 years of age; however, no observable differences were noted in mean diastolic measurements of children receiving levetiracetam vs placebo.  Similar effects have not been observed in older children and adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychiatric symptoms: Psychosis, hallucinations and behavioral symptoms (including aggression, anger, anxiety, depersonalization, depression, personality disorder) may occur; dose reduction or discontinuation may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal ideation: Pooled analysis of trials involving various antiepileptics (regardless of indication) showed an increased risk of suicidal thoughts/behavior (incidence rate: 0.43% treated patients compared to 0.24% of patients receiving placebo); risk observed as early as 1 week after initiation and continued through duration of trials (most trials &le;24 weeks). Monitor all patients for notable changes in behavior that might indicate suicidal thoughts or depression; notify healthcare provider immediately if symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use caution with renal impairment; dosage adjustment may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy of I.V. and extended release tablet formulations have not been established in children &lt;16 years of age. Children may have increased incidence of psychiatric symptoms; dose reduction or discontinuation may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Anticonvulsants should not be discontinued abruptly because of the possibility of increasing seizure frequency; therapy should be withdrawn gradually to minimize the potential of increased seizure frequency, unless safety concerns require a more rapid withdrawal.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F187612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. Management: Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions.  Monitor anticonvulsant concentrations and treatment response closely with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F187637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Food may delay, but does not affect the extent of absorption.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F187626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Developmental toxicities were observed in animal reproduction studies. Levetiracetam crosses the placenta and can be detected in the neonate at birth. Concentrations in the umbical cord at delivery are similar to those in the maternal plasma. Serum concentrations of levetiracetam may decrease as pregnancy progresses; monitor carefully throughout pregnancy and postpartum (Tomson, 2007).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Two registries are available for women exposed to levetiracetam during pregnancy: Pregnant women may enroll themselves into the North American Antiepileptic Drug (AED) Pregnancy Registry  (888-233-2334 or",
"     <a href=\"file://www.mgh.harvard.edu/aed/\" target=\"_blank\">",
"      file://www.mgh.harvard.edu/aed/",
"     </a>",
"     ). The patient or healthcare provider may contact the UCB AED Pregnancy Registry (888-537-7734).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     The North American AED registry has published data collected from pregnant women taking levetiracetam monotherapy from 1997-2011 (n=450). Eleven major malformations were diagnosed within 12 weeks of birth. The relative risk of major malformations was not increased in comparison to women with epilepsy not taking AEDs (n=442; RR 2.2, 95% CI 0.8-6.4) or in comparison to women using lamotrigine monotherapy (n=1562; RR 1.2, 95% CI 0.6-2.5) (Hern&aacute;ndez-D&iacute;az, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F187650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14385209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Levetiracetam can be detected in breast milk. Using data from 11 women collected 4-23 days after delivery, the estimated exposure of levetiracetam to the breast-feeding infant would be ~2 mg/kg/day (relative infant dose 7.9% of the weight-adjusted maternal dose). Adverse events were not reported in the nursing infants (Tomson, 2007). Breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F187627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F187625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Keppra Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/5 mL (5 mL): $51.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Keppra Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/mL (473 mL): $627.84",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Levetiracetam in NaCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/100 mL (100 mL): $32.83",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 mg/100 mL (100 mL): $54.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1500 mg/100 mL (100 mL): $81.89",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LevETIRAcetam Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg/5 mL (5 mL): $11.88",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LevETIRAcetam Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/mL (473 mL): $307.74",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 24-hour",
"     </b>",
"     (Keppra XR Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (60): $374.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (60): $562.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 24-hour",
"     </b>",
"     (LevETIRAcetam ER Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (60): $266.82",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (60): $400.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Keppra Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (120): $675.77",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (120): $825.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (120): $1118.96",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 mg (60): $825.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (LevETIRAcetam Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (120): $345.04",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (120): $421.71",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (120): $571.31",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 mg (60): $422.18",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F7740244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Suicidality (eg, suicidal thoughts, depression, behavioral changes)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F187628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ceumid (UY);",
"     </li>",
"     <li>",
"      Epilen (TW);",
"     </li>",
"     <li>",
"      Ivetra (PH);",
"     </li>",
"     <li>",
"      Keppra (AR, AT, AU, BB, BE, BG, BM, BS, CH, CL, CO, CR, CZ, DE, DK, DO, EE, ES, FI, FR, GB, GR, GT, HK, HN, ID, IE, IL, IT, JM, KP, MT, MX, MY, NI, NL, NO, NZ, PA, PE, PH, PL, PR, PT, RU, SE, SG, SK, SV, TH, TR, TT, TW);",
"     </li>",
"     <li>",
"      Keppra I.V. (AU);",
"     </li>",
"     <li>",
"      Kepra (EC);",
"     </li>",
"     <li>",
"      Kevtam (AU);",
"     </li>",
"     <li>",
"      Kopodex (CN, PE, PY);",
"     </li>",
"     <li>",
"      Letram (PH);",
"     </li>",
"     <li>",
"      Levetrim (IL);",
"     </li>",
"     <li>",
"      Levim (TW);",
"     </li>",
"     <li>",
"      Levit (PH);",
"     </li>",
"     <li>",
"      Nobelin (TW);",
"     </li>",
"     <li>",
"      Torleva (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F187606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The precise mechanism by which levetiracetam exerts its antiepileptic effect is unknown. However, several studies have suggested the mechanism may involve one or more of the following central pharmacologic effects: inhibition of voltage-dependent N-type calcium channels; facilitation of GABA-ergic inhibitory transmission through displacement of negative modulators; reduction of delayed rectifier potassium current; and/or binding to synaptic proteins which modulate neurotransmitter release.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F187622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid and almost complete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Similar to total body water",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &lt;10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Not extensive; primarily by enzymatic hydrolysis; forms metabolites (inactive)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 100%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~6-8 hours; extended release tablet: ~7 hours; half-life increased in renal dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Oral: Immediate release: ~1 hour; Extended release: ~4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (66% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Betts T, Waegemans T, and Crawford P, &ldquo;A Multicentre, Double-Blind, Randomized, Parallel Group Study to Evaluate the Tolerability and Efficacy of Two Oral Doses of Levetiracetam, 2000 mg Daily and 4000 mg Daily, Without Titration in Patients With Refractory Epilepsy,&rdquo;",
"      <i>",
"       Seizure",
"      </i>",
"      , 2000, 9(2): 80-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/10845730/pubmed\" id=\"10845730\" target=\"_blank\">",
"        10845730",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ferrendelli JA, &ldquo;Concerns With Antiepileptic Drug Initiation: Safety, Tolerability, and Efficacy,&rdquo;",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2001, 42(Suppl 4):28-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/11564122/pubmed\" id=\"11564122\" target=\"_blank\">",
"        11564122",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Glauser TA, Pellock JM, Bebin EM, et al, &ldquo;Efficacy and Safety of Levetiracetam in Children with Partial Seizures: An Open-label Trial,&rdquo;",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2002, 43(5):518-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/12027913/pubmed\" id=\"12027913\" target=\"_blank\">",
"        12027913",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hern&aacute;ndez-D&iacute;az S, Smith CR, Shen A, et al, \"Comparative Safety of Antiepileptic Drugs During Pregnancy,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2012, 8(21):1692-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/22551726/pubmed\" id=\"22551726\" target=\"_blank\">",
"        22551726",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hovinga CA, &ldquo;Levetiracetam: A Novel Antiepileptic Drug,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2001, 21(11):1375-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/11714211/pubmed\" id=\"11714211\" target=\"_blank\">",
"        11714211",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koubeissi MZ, Amina S, Pita I, et al, &ldquo;Tolerability and Efficacy of Oral Loading of Levetiracetam,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 2008, 70(22 pt 2):2166-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/18505995/pubmed\" id=\"18505995\" target=\"_blank\">",
"        18505995",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Meador KJ, Gevins A, Loring DW, et al, &ldquo;Neuropsychological and Neurophysiologic Effects of Carbamazepine and Levetiracetam,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 2007, 69(22):2076-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/18040014/pubmed\" id=\"18040014\" target=\"_blank\">",
"        18040014",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Meierkord H, Boon P, Engelsen B, et al, &ldquo;EFNS Guideline on the Management of Status Epilepticus in Adults,&rdquo;",
"      <i>",
"       Eur J Neurol",
"      </i>",
"      , 2010, 17(3):348-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/20050893/pubmed\" id=\"20050893\" target=\"_blank\">",
"        20050893",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roberts GM, Majoie HJ, Leenen LA, et al, &ldquo;Ketter's Hypothesis of the Mood Effects of Antiepileptic Drugs Coupled to the Mechanism of Action of Topiramate and Levetiracetam,&rdquo; Epilepsy Behav, 2005, 6(3):366-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/15820345/pubmed\" id=\"15820345\" target=\"_blank\">",
"        15820345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sankar R and Holmes GL, &ldquo;Mechanisms of Action for the Commonly Used Antiepileptic Drugs: Relevance to Antiepileptic Drug-Associated Neurobehavioral Adverse Effects,&rdquo;",
"      <i>",
"       J Child Neurol",
"      </i>",
"      , 2004, 19(Suppl 1):6-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/15032376/pubmed\" id=\"15032376\" target=\"_blank\">",
"        15032376",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tomson T, Palm R, K&auml;ll&eacute;n K, et al, \"Pharmacokinetics of Levetiracetam During Pregnancy, Delivery, in the Neonatal Period, and Lactation,\"",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2007, 48(6):1111-6.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Two New Drugs for Epilepsy,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 2000, 42(1076):33-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/10803174/pubmed\" id=\"10803174\" target=\"_blank\">",
"        10803174",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Uges JW, van Huizen MD, Engelsman J, et al, \"Safety and Pharmacokinetics of Intravenous Levetiracetam Infusion as Add-On in Status Epilepticus,\"",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2009, 50(3):415-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/19054418/pubmed\" id=\"19054418\" target=\"_blank\">",
"        19054418",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Welty TE, Gidal BE, Ficker DM, et al, &ldquo;Levetiracetam: A Different Approach to the Pharmacotherapy of Epilepsy,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2002,  36(2):296-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/52/43847/abstract-text/11847952/pubmed\" id=\"11847952\" target=\"_blank\">",
"        11847952",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9904 Version 52.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-89.218.100.194-EFEE8658EB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43847=[""].join("\n");
var outline_f42_52_43847=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187641\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187642\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187668\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187644\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187656\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187645\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187646\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187647\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187617\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187603\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874650\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187620\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269043\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187618\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187675\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187666\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187623\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187607\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299586\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187612\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187637\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187614\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187626\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187650\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14385209\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187627\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187625\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7740244\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187628\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187606\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187622\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9904\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9904|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/38/35429?source=related_link\">",
"      Levetiracetam: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/0/25608?source=related_link\">",
"      Levetiracetam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_52_43848="Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging";
var content_f42_52_43848=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     John A Martin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     A James Moser, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43848/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/52/43848/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periampullary tumors are neoplasms that arise in the vicinity of the ampulla of Vater. They can originate from the pancreas, duodenum, distal common bile duct (CBD), or the structures of the ampullary (ampulla of Vater) complex. The ampulla of Vater is formed by the duodenal aspect of the sphincter of Oddi muscle, which surrounds the confluence of the distal CBD and main pancreatic duct as well as the papilla of Vater, a mucosal papillary mound at the distal insertion of these ducts on the medial wall of the duodenum (",
"    <a class=\"graphic graphic_figure graphicRef78786 \" href=\"mobipreview.htm?27/17/27924\">",
"     figure 1",
"    </a>",
"    ). Ampullary carcinomas are defined as those that arise within the ampullary complex, distal to the bifurcation of the distal common bile duct and the pancreatic duct (",
"    <a class=\"graphic graphic_figure graphicRef53240 \" href=\"mobipreview.htm?5/49/5908\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The papilla is a nipple-like structure on the medial aspect of the second portion of the duodenum best visualized with a side-viewing endoscope. The distal bile and ventral pancreatic ducts traverse the duodenal wall in this location and open into the duodenal lumen through the small mucosal elevation of the papilla of Vater.",
"   </p>",
"   <p>",
"    The epidemiology, clinical features, diagnosis, and staging of ampullary carcinoma will be reviewed here. Treatment of ampullary cancers and the approach to the patient with ampullary adenoma is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/37/3674?source=see_link\">",
"     \"Ampullary carcinoma: Treatment and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26950?source=see_link\">",
"     \"Clinical manifestations and diagnosis of ampullary adenomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/36/13897?source=see_link\">",
"     \"Treatment of ampullary adenomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND BIOLOGIC BEHAVIOR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neoplastic transformation of the intestinal mucosa occurs more commonly near the ampulla than at any other site in the small intestine. Despite this, primary ampullary tumors are rare, with an incidence of approximately four to six cases per million population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. They account for only 6 percent of lesions that arise in the periampullary region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/5\">",
"     5",
"    </a>",
"    ] but are responsible for 20 percent of all tumor-related obstructions of the CBD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/6\">",
"     6",
"    </a>",
"    ]. There is some evidence that the incidence has increased over the last 30 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both benign and malignant ampullary tumors can occur sporadically or in the setting of a genetic syndrome. The incidence of ampullary tumors is increased 200- to 300-fold among patients with hereditary polyposis syndromes, such as familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) compared with the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Surveillance endoscopy is particularly important to detect early ampullary lesions in patients with FAP given the high incidence of coexisting premalignant duodenal adenomatous polyps. Up to 90 percent of patients with FAP develop adenomas in the upper gastrointestinal tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/14/16618?source=see_link\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The average age at diagnosis of sporadic ampullary carcinomas is 60 to 70 years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/8,11-13\">",
"     8,11-13",
"    </a>",
"    ]. In contrast, patients whose ampullary carcinomas arise in the setting of an inherited polyposis syndrome usually present at an earlier age, due in part to endoscopic screening and surveillance programs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Biologic behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several lines of evidence suggest that the biology of primary ampullary adenomas and carcinomas is more analogous to intestinal rather than pancreatic neoplasms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The histology of primary ampullary neoplasms resembles adenomas and adenocarcinomas of intestinal origin rather than pancreaticobiliary origin. In one study of 170 ampullary carcinomas, the most common histologic subtype was intestinal (47 percent), followed by pancreatobiliary (24 percent), poorly differentiated adenocarcinomas (13 percent), intestinal-mucinous (8 percent), and invasive papillary (5 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ampullary carcinomas are thought to arise from ampullary adenomas, a premalignant precursor lesion displaying the adenoma-carcinoma sequence observed in colorectal neoplasia. Moreover, patients with FAP have a significantly increased incidence of both ampullary and colorectal cancers relative to the general population, suggesting that the mechanism of ampullary and colorectal carcinogenesis may be similar [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      K-ras mutations are an early event in ampullary carcinogenesis, with an incidence (37 percent) that is similar to that in colon cancer (up to 50 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/16\">",
"       16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=see_link&amp;anchor=H10#H10\">",
"       \"Molecular genetics of colorectal cancer\", section on 'Oncogenes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Expression profiling of cyclooxygenase-2 (COX-2) by ampullary carcinomas is more consistent with a neoplasm of intestinal origin than pancreaticobiliary origin. High COX-2 expression has been detected in 78 percent of ampullary carcinomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/17\">",
"       17",
"      </a>",
"      ]. Of ampullary carcinomas classified as having an intestinal origin, 95 percent had high COX-2 expression, whereas only 50 percent of lesions with a pancreaticobiliary origin demonstrated high COX-2 expression.",
"     </li>",
"     <li>",
"      True ampullary cancers have a better prognosis than periampullary malignancies of pancreatic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/18-20\">",
"       18-20",
"      </a>",
"      ] or extrahepatic biliary [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/21\">",
"       21",
"      </a>",
"      ] origin. Resectability rates are higher (over 90 percent in some contemporary series), and five-year survival rates are approximately 30 to 50 percent, even in patients with lymph node involvement. In contrast, fewer than 10 percent of patients with completely resected node-positive pancreatic cancer are alive at two years. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/34/8746?source=see_link\">",
"       \"Surgery in the treatment of exocrine pancreatic cancer and prognosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/37/3674?source=see_link\">",
"       \"Ampullary carcinoma: Treatment and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because it can be difficult to distinguish a primary ampullary carcinoma from other periampullary tumors preoperatively, an aggressive approach to diagnosis and treatment is needed to ensure that patients with these comparatively favorable cancers are treated optimally.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with ampullary adenomas, the most common presenting symptom of ampullary carcinoma is obstructive jaundice (80 percent) caused by compression of the distal bile duct by the tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/11,22\">",
"     11,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26950?source=see_link\">",
"     \"Clinical manifestations and diagnosis of ampullary adenomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ampullary cancers are not usually suspected as a cause of obstructive jaundice because of their lower incidence relative to other periampullary malignancies. Additional symptoms may include diarrhea due to fat malabsorption (steatorrhea), mild weight loss, and fatigue.",
"   </p>",
"   <p>",
"    Up to one-third of patients have chronic, frequently occult gastrointestinal blood loss with an associated microcytic anemia or heme-positive stools. Patients occasionally present with frank bleeding due to sloughing of the tumor, a condition exacerbated by the use of antiplatelet agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    . In one report, nonspecific symptoms include abdominal pain (45 percent), fever (45 percent), mild nausea, and dyspepsia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/23\">",
"     23",
"    </a>",
"    ]. Large lesions may produce gastric outlet obstruction associated with severe nausea and vomiting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of an ampullary carcinoma is established by a combination of endoscopic, radiologic, and histologic features. Accurate staging is essential for planning surgical treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     TNM staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly used staging system is the tumor-node-metastasis (TNM) system of the combined AJCC (American Joint Committee on",
"    <span class=\"nowrap\">",
"     Cancer)/UICC",
"    </span>",
"    (International Union Against Cancer) (",
"    <a class=\"graphic graphic_table graphicRef77606 \" href=\"mobipreview.htm?39/13/40156\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of metastases, the prognosis of an ampullary carcinoma depends primarily upon two factors: the degree of local tumor invasion, as reflected by the T stage, and the presence of lymphatic spread, as reflected by the N stage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic evaluation of a jaundiced patient with a suspected malignant bile duct obstruction is designed to eliminate benign tumors or gallstones from the differential, and to establish the extent of tumor invasion and spread. Although advanced endoscopic techniques can help to differentiate ampullary adenomas from carcinomas, it may be difficult to completely exclude a carcinoma without complete resection of the lesion. Ampullary adenomas have the potential to undergo malignant transformation, and an occult focus of carcinoma may be present within a predominantly benign adenoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26950?source=see_link\">",
"     \"Clinical manifestations and diagnosis of ampullary adenomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Differentiating a primary ampullary carcinoma from other more common periampullary malignancies (arising in the pancreas, duodenum, or bile duct) is challenging. Although the distinction may be evident after radiographic and endoscopic evaluation, it may not be possible to determine the tissue origin of a malignant periampullary neoplasm until resection and histopathologic evaluation of the entire surgical specimen is completed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/25\">",
"     25",
"    </a>",
"    ]. This is particularly true if the lesion is large and obstructs the duodenal lumen. From a surgical standpoint, the distinction between ampullary and periampullary cancers is not essential preoperatively since the treatment is the same for both lesions. However, the oncologic implications and prognosis of the ampullary and periampullary tumors are substantially different. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/34/8746?source=see_link\">",
"     \"Surgery in the treatment of exocrine pancreatic cancer and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10937?source=see_link&amp;anchor=H20#H20\">",
"     \"Diagnosis and staging of small bowel neoplasms\", section on 'Adenocarcinoma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\", section on 'Distal cholangiocarcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Transabdominal ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transabdominal ultrasonography (US) should be the first imaging study ordered for patients with jaundice, since US can identify intrahepatic and extrahepatic bile duct dilatation and gallstones. However, overlying bowel gas frequently obscures the distal bile duct, ampulla, and pancreas. In one study, only 10 of 127 ampullary masses were detected by ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/26\">",
"     26",
"    </a>",
"    ]. The overall accuracy was 15 percent, according to one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/27\">",
"     27",
"    </a>",
"    ]. As a result, abdominal CT should be ordered as the next diagnostic procedure if US does not demonstrate gallstones or an obvious pancreatic head mass in a jaundiced patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Abdominal CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT is more sensitive than US for evaluating the periampullary region (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63759 \" href=\"mobipreview.htm?15/43/16048\">",
"     image 1",
"    </a>",
"    ). A \"pancreatic mass protocol\" CT should be ordered. Specifically, patients should receive water as the oral \"contrast agent\" (to distend the duodenum and improve visualization of the duodenal lumen and adjacent pancreas), and IV contrast is injected as a bolus to permit both arterial- and venous-phase imaging. Images are acquired at 1.0 to 2.5 mm intervals to improve the sensitivity of pancreatic imaging. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41610?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although helical CT can detect masses obstructing the distal CBD, its sensitivity usually does not permit the visualization of small ampullary neoplasms within the duodenal lumen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/28\">",
"     28",
"    </a>",
"    ]. In one report, the overall accuracy was only 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/27\">",
"     27",
"    </a>",
"    ]. Furthermore, CT by itself is inadequate for staging ampullary cancers because it lacks the spatial resolution to determine the degree of local tumor invasion into the duodenal wall, adjacent pancreas, or the presence of major vascular involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/29\">",
"     29",
"    </a>",
"    ]. On the other hand, CT is generally the most useful study to evaluate for the presence of distant metastatic disease which most frequently involves the regional lymph nodes, liver, peritoneum, lungs, and bone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     ERCP (endoscopic retrograde cholangiopancreatography)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a jaundiced patient with suspected malignant bile duct obstruction, ERCP is the preferred initial endoscopic study since it permits simultaneous endoscopic visualization of the ampulla, cholangiography of the pancreatic and bile ducts, biopsy from the papilla and ampullary segment of the CBD or pancreatic duct, and placement of a stent for biliary decompression, if necessary and technically feasible. However, ERCP cannot determine the extent of local tumor invasion of an ampullary carcinoma into the adjacent duodenum or pancreatic parenchyma, information that is essential for preoperative staging and surgical planning.",
"   </p>",
"   <p>",
"    Most ampullary cancers are obvious endoscopically (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70689 \" href=\"mobipreview.htm?36/34/37408\">",
"     image 2",
"    </a>",
"    ). If an exophytic ampullary tumor is identified that has the appearance of an adenoma, malignancy should be strongly suspected if the mass is ulcerated or over 3 cm in size. However, because the false negative rate of endoscopic biopsy is as high as 50 percent, a negative result is insufficient to exclude the presence of malignancy in an ampullary lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/30-35\">",
"     30-35",
"    </a>",
"    ]. The overall accuracy of diagnosis with ERCP in one report was 88 percent (p&gt;0.05) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Attempts to enhance the accuracy of endoscopic biopsy include the acquisition of tissue at least 48 hours following sphincterotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/37,38\">",
"     37,38",
"    </a>",
"    ], the performance of multiple biopsies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/39\">",
"     39",
"    </a>",
"    ], and the use of polymerase chain reaction (PCR) or immunohistochemical staining to detect p53 (a tumor suppressor gene that is frequently lost in periampullary neoplasms) or K-ras gene mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/16,40-44\">",
"     16,40-44",
"    </a>",
"    ]. None of these methods are used routinely in current clinical practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     MRCP and percutaneous transhepatic cholangiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ampullary obstruction can also be evaluated by magnetic resonance cholangiopancreatography (MRCP) or percutaneous transhepatic cholangiography (PTC) in patients with contraindications to ERCP (eg, those who have undergone gastric surgery, such as a Roux-en-Y gastrojejunostomy, with resultant anatomy that may make endoscopic access of the duodenum technically challenging or impossible, even with deep enteroscopy techniques). However, neither of these imaging modalities permits direct luminal visualization of the papillary aspect of the ampulla, nor do they provide access for tissue acquisition via direct forceps biopsy.",
"   </p>",
"   <p>",
"    MRCP is a noninvasive method of imaging the pancreaticobiliary tree via MRI. Some authors recommend this approach in place of ERCP in patients who will not tolerate invasive procedures or in whom a large tumor occludes the orifice of the pancreaticobiliary ducts, thus preventing cannulation and duct opacification at the time of ERCP. Ampullary carcinomas appear as masses (filling defects) protruding into the duodenal lumen, with characteristic delayed enhancement and hyperintensity on diffusion-weighted imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. In one report the overall accuracy of diagnosis with MRCP was 76 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, PTC is an invasive procedure during which the biliary tree is accessed percutaneously using a needle inserted through the parenchyma of the liver into an intrahepatic bile duct, then contrast opacified under fluoroscopy. PTC is most commonly performed when the biliary tree is dilated and ERCP has failed to cannulate or adequately demonstrate the biliary anatomy. PTC provides not only cholangiography but also the opportunity for brush cytology (although not forceps biopsy for histology) of radiographic strictures, although ampullary lesions that do not extend into the distal CBD may not be amenable to tissue acquisition via this route. Another limitation of PTC is that it cannot directly visualize ampullary lesions, duodenal tumor ingrowth, or involvement of the pancreatic duct. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/39/37491?source=see_link\">",
"     \"Percutaneous transhepatic cholangiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Endoscopic ultrasonography (EUS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasonography (EUS) is as sensitive as ERCP and superior to CT and transabdominal US for detecting small ampullary tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/27,45,47-55\">",
"     27,45,47-55",
"    </a>",
"    ]. Furthermore, EUS may identify an invasive carcinoma that was not evident on other imaging tests or endoscopic biopsies (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72481 \" href=\"mobipreview.htm?33/58/34735\">",
"     image 3",
"    </a>",
"    ). However, the great majority of cancers are obvious endoscopically, and EUS is not helpful for those benign lesions that contain only a small focus of adenocarcinoma other than to ascertain lack of invasive carcinoma. On the other hand, EUS may be a useful diagnostic modality for the occasional biopsy-negative ampullary lesion that has equivocal endoscopic features of malignancy.",
"   </p>",
"   <p>",
"    Although EUS cannot exclude the presence of a malignant focus within an adenoma, fine-needle aspiration (FNA) of the ampulla, papilla, and surrounding deeper structures including local lymph nodes can be obtained during the procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one report, the overall accuracy of EUS-guided fine-needle aspiration biopsy (FNAB) for primary masses of the ampullary region was 89 percent with a sensitivity 82 percent, specificity of 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/56\">",
"     56",
"    </a>",
"    ]. Because biliary and pancreatic sphincterotomy and stent placement cannot be achieved during EUS, patients who require therapeutic intervention must also undergo an ERCP, which can be performed concomitantly.",
"   </p>",
"   <p>",
"    The utility of EUS is far greater for preoperative staging of ampullary carcinomas than it is for diagnosis. EUS is capable of obtaining images of the distal biliary and pancreatic ducts, permitting assessment of local intraductal tumor extension. Furthermore, EUS accurately demonstrates the depth of tumor penetration into the duodenum by demonstrating obliteration of the interface between the tumor and the muscularis propria of the duodenum (a feature that upstages the tumor to T2). Tumor extension into the pancreas is assessed by the depth of invasion (&lt;2 cm signifying T3, and &gt;2 cm or contiguous spread to adjacent organs signifying T4 disease).",
"   </p>",
"   <p>",
"    EUS is the most accurate modality available to assess the T-stage of ampullary tumors, which is critical for planning surgical intervention. Multiple series consistently document primary tumor (T) staging accuracies of 70 to 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/7,47,49,52,57-63\">",
"     7,47,49,52,57-63",
"    </a>",
"    ]. EUS staging methods tend to overestimate, rather than underestimate, the depth of tumor invasion and resulting T stage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/6\">",
"     6",
"    </a>",
"    ]. Accuracy may be decreased in the presence of an endobiliary stent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EUS is less accurate for nodal (N) staging. Ampullary cancers drain into two lymph node basins: the retroduodenopancreatic chain and the superior mesenteric chain. One study reported a sensitivity and specificity of 67 and 96 percent, respectively, for EUS detection of nodal metastases when abnormal nodes were defined as those over one centimeter in diameter and located in the above two positions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/63\">",
"     63",
"    </a>",
"    ]. Another series found sensitivity and specificity rates of 69 and 38 percent when all visualized lymph nodes present around the duodenopancreatic block were presumed to be metastatic, regardless of size or position [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/62\">",
"     62",
"    </a>",
"    ]. However, others have reported sensitivity rates as low as 21 percent for detection of nodal metastases by EUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EUS-guided FNA of suspicious lymph nodes may further increase the accuracy of nodal staging. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3561?source=see_link&amp;anchor=H109379223#H109379223\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\", section on 'Pancreatic masses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Intraductal ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technical evolution of EUS has led to the development of small caliber intraductal ultrasound (IDUS) miniprobes (~2 mm), which can be passed through standard endoscopes directly into the bile or pancreatic duct. The small caliber, flexibility, and excellent image quality produced by these catheters makes them useful for evaluating a variety of biliary and pancreatic disorders. IDUS accurately visualizes the anatomy of the papilla and is the only procedure that reliably differentiates the sphincter of Oddi muscle from the remainder of the papilla. As a result, IDUS can be useful for diagnosing and assessing the size and extent of papillary tumors. In a study of 40 patients with ampullary carcinoma, EUS was more accurate than EUS for T-staging and evaluating ductal invasion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33353?source=see_link\">",
"     \"Intraductal ultrasound of the pancreaticobiliary ductal system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Magnification endoscopy with narrow band imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Narrow band imaging uses optical filters to enhance visualization of microvessels and mucosal surface architecture in gastrointestinal diseases. The technique demonstrates abnormal vessels associated with high-grade dysplasia on the surface of high-grade adenomas and adenocarcinomas. Abnormal vessels have not been identified on the surface of benign ampullary adenomas with hyperplastic or inflammatory histology. Preliminary studies have suggested a potential role for evaluation of ampullary lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Liver biochemical tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood chemistries cannot establish the diagnosis of ampullary carcinoma, but may reflect the presence of cholestasis when an ampullary neoplasm results in partial or complete biliary obstruction. Patients generally have a cholestatic pattern of liver biochemical test abnormalities, although aminotransferases may also be elevated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/23\">",
"     23",
"    </a>",
"    ]. The prothrombin time may be elevated due to impaired absorption of fat-soluble vitamins including vitamin K [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Serum tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum tumor markers are not specific for ampullary carcinomas and have limited diagnostic application. Nevertheless, some ampullary cancers are associated with increased serum levels of carbohydrate antigen CA 19-9",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    carcinoembryonic antigen (CEA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43848/abstract/19,68\">",
"     19,68",
"    </a>",
"    ], and serial assay of these tumor markers may be useful for posttreatment follow-up. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/37/3674?source=see_link&amp;anchor=H23#H23\">",
"     \"Ampullary carcinoma: Treatment and prognosis\", section on 'Posttreatment surveillance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with ampullary cancer most commonly present with jaundice (80 percent) caused by obstruction of the distal bile duct by tumor. Diagnosis and staging are achieved by a combination of endoscopic, radiologic, and histologic features (",
"    <a class=\"graphic graphic_algorithm graphicRef51015 \" href=\"mobipreview.htm?39/5/40030\">",
"     algorithm 1",
"    </a>",
"    ). There are two major considerations: identification of the tumor, and distinction from an ampullary adenoma or tumor arising from outside of the ampulla (mainly pancreatic carcinoma or a distal cholangiocarcinoma).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A transabdominal ultrasound is a reasonable first test in patients presenting with obstructive jaundice, but it will generally not show the tumor. Helical CT scan should be obtained to visualize the pancreas and surrounding structures. Although its spatial resolution is inadequate to determine the degree of local tumor invasion, it is the most useful test to exclude the presence of distant metastases. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Transabdominal ultrasonography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      ERCP is the single most useful endoscopic study since it permits identification of the tumor, biopsy, and decompression, if needed. However, endoscopic ultrasonography is the most accurate means of staging the tumor for treatment planning purposes, and confirming the diagnosis with an EUS-guided fine-needle aspiration biopsy (FNA). If available, it may be prudent to perform EUS prior to undertaking therapeutic ERCP. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'ERCP (endoscopic retrograde cholangiopancreatography)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Endoscopic ultrasonography (EUS)'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/1\">",
"      Neoptolemos JP, Talbot IC, Carr-Locke DL, et al. Treatment and outcome in 52 consecutive cases of ampullary carcinoma. Br J Surg 1987; 74:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/2\">",
"      Benhamiche AM, Jouve JL, Manfredi S, et al. Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol 2000; 12:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/3\">",
"      Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 2009; 100:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/4\">",
"      Goodman MT, Yamamoto J. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002. Cancer Causes Control 2007; 18:415.",
"     </a>",
"    </li>",
"    <li>",
"     Brennan MF. Surgical management of peripancreatic cancer. In: Atlas of Surgical Oncology, Bland KL, Karakoukis CP, Copeland, EM (Eds), WB Saunders Company, Philadelphia 1995. p.473.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/6\">",
"      Palazzo L. Staging of ampullary carcinoma by endoscopic ultrasonography. Endoscopy 1998; 30 Suppl 1:A128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/7\">",
"      Quirk DM, Rattner DW, Fernandez-del Castillo C, et al. The use of endoscopic ultrasonography to reduce the cost of treating ampullary tumors. Gastrointest Endosc 1997; 46:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/8\">",
"      Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/9\">",
"      Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial polyposis. Lancet 1988; 332:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/10\">",
"      Church J, Simmang C, Standards Task Force, et al. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 2003; 46:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/11\">",
"      Monson JR, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991; 126:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/12\">",
"      Nakase A, Matsumoto Y, Uchida K, Honjo I. Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan. Ann Surg 1977; 185:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/13\">",
"      O'Connell JB, Maggard MA, Manunga J Jr, et al. Survival after resection of ampullary carcinoma: a national population-based study. Ann Surg Oncol 2008; 15:1820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/14\">",
"      Ruemmele P, Dietmaier W, Terracciano L, et al. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol 2009; 33:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/15\">",
"      Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001; 16:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/16\">",
"      Howe JR, Klimstra DS, Cordon-Cardo C, et al. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res 1997; 3:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/17\">",
"      Perrone G, Santini D, Zagami M, et al. COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters. Virchows Arch 2006; 449:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/18\">",
"      Morris-Stiff G, Alabraba E, Tan YM, et al. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol 2009; 35:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/19\">",
"      Smith RA, Ghaneh P, Sutton R, et al. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg 2008; 12:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/20\">",
"      Sommerville CA, Limongelli P, Pai M, et al. Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors. J Surg Oncol 2009; 100:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/21\">",
"      Woo SM, Ryu JK, Lee SH, et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 2007; 14:3195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/22\">",
"      Smith RC. Surgical treatment for ampullary carcinoma. Aust N Z J Surg 1999; 69:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/23\">",
"      Tsukada K, Takada T, Miyazaki M, et al. Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008; 15:31.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.235.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/25\">",
"      Camp ER, Vogel SB. Blind Whipple resections for periampullary and pancreatic lesions. Am Surg 2004; 70:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/26\">",
"      Qiao QL, Zhao YG, Ye ML, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg 2007; 31:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/27\">",
"      Skordilis P, Mouzas IA, Dimoulios PD, et al. Is endosonography an effective method for detection and local staging of the ampullary carcinoma? A prospective study. BMC Surg 2002; 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/28\">",
"      Bakkevold KE, Arnesj&oslash; B, Kambestad B. Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial. Scand J Gastroenterol 1992; 27:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/29\">",
"      Rivadeneira DE, Pochapin M, Grobmyer SR, et al. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann Surg Oncol 2003; 10:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/30\">",
"      Ryan DP, Schapiro RH, Warshaw AL. Villous tumors of the duodenum. Ann Surg 1986; 203:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/31\">",
"      Posner S, Colletti L, Knol J, et al. Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of Vater. Surgery 2000; 128:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/32\">",
"      Clary BM, Tyler DS, Dematos P, et al. Local ampullary resection with careful intraoperative frozen section evaluation for presumed benign ampullary neoplasms. Surgery 2000; 127:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/33\">",
"      Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/34\">",
"      Yamaguchi K, Enjoji M, Kitamura K. Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 1990; 36:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/35\">",
"      Sauvanet A, Chapuis O, Hammel P, et al. Are endoscopic procedures able to predict the benignity of ampullary tumors? Am J Surg 1997; 174:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/36\">",
"      Domagk D, Wessling J, Reimer P, et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am J Gastroenterol 2004; 99:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/37\">",
"      Ponchon T, Berger F, Chavaillon A, et al. Contribution of endoscopy to diagnosis and treatment of tumors of the ampulla of Vater. Cancer 1989; 64:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/38\">",
"      Bourgeois N, Dunham F, Verhest A, Cremer M. Endoscopic biopsies of the papilla of Vater at the time of endoscopic sphincterotomy: difficulties in interpretation. Gastrointest Endosc 1984; 30:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/39\">",
"      Shemesh E, Nass S, Czerniak A. Endoscopic sphincterotomy and endoscopic fulguration in the management of adenoma of the papilla of Vater. Surg Gynecol Obstet 1989; 169:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/40\">",
"      Park SH, Kim YI, Park YH, et al. Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. World J Surg 2000; 24:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/41\">",
"      Sato T, Konishi K, Kimura H, et al. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA. Hepatogastroenterology 1999; 46:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/42\">",
"      Takashima M, Ueki T, Nagai E, et al. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol 2000; 13:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/43\">",
"      Younes M, Riley S, Genta RM, et al. p53 protein accumulation in tumors of the ampulla of Vater. Cancer 1995; 76:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/44\">",
"      Chung CH, Wilentz RE, Polak MM, et al. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol 1996; 49:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/45\">",
"      Irie H, Honda H, Shinozaki K, et al. MR imaging of ampullary carcinomas. J Comput Assist Tomogr 2002; 26:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/46\">",
"      Jang KM, Kim SH, Lee SJ, et al. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma. Radiology 2013; 266:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/47\">",
"      Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999; 50:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/48\">",
"      Mukai H, Nakajima M, Yasuda K, et al. Evaluation of endoscopic ultrasonography in the pre-operative staging of carcinoma of the ampulla of Vater and common bile duct. Gastrointest Endosc 1992; 38:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/49\">",
"      R&ouml;sch T, Braig C, Gain T, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/50\">",
"      Tio TL, Mulder CJ, Eggink WF. Endosonography in staging early carcinoma of the ampulla of vater. Gastroenterology 1992; 102:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/51\">",
"      Chen CH, Tseng LJ, Yang CC, et al. The accuracy of endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, computed tomography, and transabdominal ultrasound in the detection and staging of primary ampullary tumors. Hepatogastroenterology 2001; 48:1750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/52\">",
"      Midwinter MJ, Beveridge CJ, Wilsdon JB, et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/53\">",
"      M&uuml;ller MF, Meyenberger C, Bertschinger P, et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/54\">",
"      Howard TJ, Chin AC, Streib EW, et al. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg 1997; 174:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/55\">",
"      Snady H, Cooperman A, Siegel J. Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointest Endosc 1992; 38:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/56\">",
"      Defrain C, Chang CY, Srikureja W, et al. Cytologic features and diagnostic pitfalls of primary ampullary tumors by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2005; 105:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/57\">",
"      Kubo H, Chijiiwa Y, Akahoshi K, et al. Pre-operative staging of ampullary tumours by endoscopic ultrasound. Br J Radiol 1999; 72:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/58\">",
"      Buscail L, Pag&egrave;s P, Berth&eacute;lemy P, et al. Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 1999; 50:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/59\">",
"      Mitake M, Nakazawa S, Tsukamoto Y, et al. Endoscopic ultrasonography in the diagnosis of depth invasion and lymph node metastasis of carcinoma of the papilla of Vater. J Ultrasound Med 1990; 9:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/60\">",
"      Tio TL, Tytgat GN, Cikot RJ, et al. Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990; 175:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/61\">",
"      Mukai H, Yasuda K, Nakajima M. Tumors of the papilla and distal common bile duct. Diagnosis and staging by endoscopic ultrasonography. Gastrointest Endosc Clin N Am 1995; 5:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/62\">",
"      Tio TL, Sie LH, Kallimanis G, et al. Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery. Gastrointest Endosc 1996; 44:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/63\">",
"      Itoh A, Goto H, Naitoh Y, et al. Intraductal ultrasonography in diagnosing tumor extension of cancer of the papilla of Vater. Gastrointest Endosc 1997; 45:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/64\">",
"      Shoup M, Hodul P, Aranha GV, et al. Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg 2000; 179:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/65\">",
"      Ito K, Fujita N, Noda Y, et al. Preoperative evaluation of ampullary neoplasm with EUS and transpapillary intraductal US: a prospective and histopathologically controlled study. Gastrointest Endosc 2007; 66:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/66\">",
"      Uchiyama Y, Imazu H, Kakutani H, et al. New approach to diagnosing ampullary tumors by magnifying endoscopy combined with a narrow-band imaging system. J Gastroenterol 2006; 41:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/67\">",
"      Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51 Suppl 6:VI1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43848/abstract/68\">",
"      Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003; 10:1176.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 655 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-210.101.131.232-8FC26C7E2B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43848=[""].join("\n");
var outline_f42_52_43848=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND BIOLOGIC BEHAVIOR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Biologic behavior",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS AND STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TNM staging system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Transabdominal ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Abdominal CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ERCP (endoscopic retrograde cholangiopancreatography)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MRCP and percutaneous transhepatic cholangiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Endoscopic ultrasonography (EUS)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Intraductal ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Magnification endoscopy with narrow band imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Liver biochemical tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Serum tumor markers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/655\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/655|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?39/5/40030\" title=\"algorithm 1\">",
"      Ampullary carcinoma algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/655|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/43/16048\" title=\"diagnostic image 1\">",
"      Ampullary carcinoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?36/34/37408\" title=\"diagnostic image 2\">",
"      Ampullary cancer ENDO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?33/58/34735\" title=\"diagnostic image 3\">",
"      Ampullary carcinoma EUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/655|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/17/27924\" title=\"figure 1\">",
"      Sphincter of Oddi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/49/5908\" title=\"figure 2\">",
"      Locations ampullary tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/655|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/13/40156\" title=\"table 1\">",
"      TNM staging ampullary CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/37/3674?source=related_link\">",
"      Ampullary carcinoma: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26950?source=related_link\">",
"      Clinical manifestations and diagnosis of ampullary adenomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41610?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/43/10937?source=related_link\">",
"      Diagnosis and staging of small bowel neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3561?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/14/16618?source=related_link\">",
"      Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33353?source=related_link\">",
"      Intraductal ultrasound of the pancreaticobiliary ductal system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/39/37491?source=related_link\">",
"      Percutaneous transhepatic cholangiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/34/8746?source=related_link\">",
"      Surgery in the treatment of exocrine pancreatic cancer and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/36/13897?source=related_link\">",
"      Treatment of ampullary adenomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=related_link\">",
"      Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_52_43849="Atypical hemolytic uremic syndrome in children";
var content_f42_52_43849=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Atypical hemolytic uremic syndrome in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/52/43849/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43849/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/52/43849/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43849/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/52/43849/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/52/43849/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/52/43849/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hemolytic-uremic syndrome (HUS) is defined by the simultaneous occurrence of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/1\">",
"     1",
"    </a>",
"    ]. It is one of the main causes of acute renal failure in children younger than the age of three years. HUS commonly affects multiple other organ systems, including the central nervous system (CNS).",
"   </p>",
"   <p>",
"    HUS can be divided into two forms based upon the clinical presentation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atypical HUS is a heterogeneous disorder distinguished by the absence of diarrhea or Shiga toxin-producing E. coli infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/1-4\">",
"       1-4",
"      </a>",
"      ]. It is responsible for only 10 percent of cases in children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]. This disorder is also referred to as atypical, nondiarrhea-associated HUS, D- HUS, or sporadic HUS.",
"     </li>",
"     <li>",
"      Typical or Shiga toxin associated HUS is the most common form of HUS in children accounting for 90 percent of all cases. It usually occurs after a prodromal episode of diarrhea that is frequently bloody. In the majority of cases, HUS is associated with strains of Escherichia coli that produce a Shiga toxin. This form is also referred to as diarrhea-associated HUS, D+ HUS, or Shiga toxin-associated HUS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of atypical HUS in children are presented in this topic review. The following discussion is based largely upon epidemiologic, pathologic, and clinical studies performed",
"    <strong>",
"     prior",
"    </strong>",
"    to any knowledge concerning any of the known genetic defects as well as other possible abnormalities underlying this disorder. Thus, the clinical features described in these studies are likely to include those of patients with varying underlying pathogenic defects. The clinical features of children with known specific defects resulting in atypical HUS are described below.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, treatment, and prognosis of typical HUS are also presented separately (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/55/35704?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/59/30649?source=see_link\">",
"     \"Treatment and prognosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the usual absence of a diarrheal prodrome, children with atypical hemolytic-uremic syndrome (HUS) have a different presentation and clinical course than those with typical HUS.",
"   </p>",
"   <p>",
"    One retrospective 1993 study reported the clinical manifestations and outcomes in 20 children with atypical HUS seen over the previous 20 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/4\">",
"     4",
"    </a>",
"    ]. There was a nonspecific prodromal illness, which did not include diarrhea, had no seasonal predilection, and markedly increased blood pressure. Outcomes were poor: five died; four developed end-stage renal disease (ESRD); and all but two surviving children had evidence of permanent renal insufficiency. Among the 11 treated with plasma exchange, all initially recovered renal function, but 10 subsequently developed clinical relapses.",
"   </p>",
"   <p>",
"    This and other studies have suggested that atypical HUS in children is largely characterized by the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Absence of a prodromal phase or nongastrointestinal prodrome",
"     </li>",
"     <li>",
"      Insidious onset",
"     </li>",
"     <li>",
"      Extended protracted course prior to the development of severe renal dysfunction function",
"     </li>",
"     <li>",
"      Poor outcomes",
"     </li>",
"     <li>",
"      Relapsing or progressive course",
"     </li>",
"     <li>",
"      Permanent renal sequelae including hypertension and renal dysfunction or failure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, not all studies have found that atypical disease is associated with a very different presentation, clinical course, and prognosis from those observed with typical disease. To directly compare the clinical features and outcomes of the two disorders, a single-center 1996 retrospective study in the United States examined the clinical manifestations and outcomes of 28 episodes of atypical HUS (in 22 children) with that of 266 episodes of typical HUS (in 265 children) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/2\">",
"     2",
"    </a>",
"    ]. HUS was defined as the acute onset of microangiopathic hemolytic anemia and acute nephropathy in a child, with a normal platelet count not being an excluding feature (as some reports suggest that thrombocytopenia is not observed in 6 percent of cases of HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/7\">",
"     7",
"    </a>",
"    ]). The absence or presence of prodromal diarrhea also defined the cases as either atypical or typical HUS, respectively. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With atypical disease, prodromal features included upper respiratory infection, fever, and vomiting in 23, 46, and 81 percent of cases, respectively, which was not significantly different from typical HUS (other than the absence of diarrhea).",
"     </li>",
"     <li>",
"      The hematocrit and platelet counts were similar, but the serum creatinine concentration at hospitalization was significantly lower in the atypical group (1.2 versus 2.2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [106 versus 221",
"      <span class=\"nowrap\">",
"       micromol/L]).",
"      </span>",
"     </li>",
"     <li>",
"      Atypical disease was significantly less likely to result in oliguria (28 and 58 percent) and anuria (16 and 41 percent), or to require dialysis (21 and 47 percent).",
"     </li>",
"     <li>",
"      Mortality rates were 3.4 and 0 percent in patients with typical and atypical HUS.",
"     </li>",
"     <li>",
"      At follow-up (approximately five to six years), no significant differences were noted concerning the incidence of hypertension, decreased renal function, proteinuria, or the combination of these features. In addition, the incidence of ESRD was similar in both groups.",
"     </li>",
"     <li>",
"      Recurrent disease occurred in only 18 percent of patients with atypical disease, with two of the four eventually developing ESRD. The other two had familial HUS (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Genetic forms of HUS'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other comparative studies, however, have reported marked differences in the short-term course among typical and atypical HUS. One multicenter study compared the clinical characteristics of 24 and 145 children with D- HUS and D+ HUS, respectively, who were enrolled from 1997 to 2001 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/3\">",
"     3",
"    </a>",
"    ]. Compared with children with D+ HUS, those with D- HUS had longer hospital stays, more frequently required dialysis (71 versus 42 percent), and had an increased number of serious extrarenal complications. However, there were no fatalities among the children with atypical disease.",
"   </p>",
"   <p>",
"    Thus, children with atypical HUS have a varied clinical presentation and course as a result of the different underlying causes. Unlike patients with typical HUS, some children with atypical HUS have an insidious onset and are at a high risk of death, disease recurrence,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chronic renal disease. By comparison, others present similarly to those with typical disease, with some even exhibiting a lesser degree of renal involvement, and having relatively good long-term outcomes.",
"   </p>",
"   <p>",
"    Several cases of sporadic HUS have been reported in association with low C3 levels, a finding observed in some (but not all) families with familial HUS. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Genetic forms of HUS'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The renal histological lesion in atypical HUS is most often arteriolar thrombotic microangiopathy perhaps accounting for the markedly increased blood pressure seen in some patients with atypical disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/8\">",
"     8",
"    </a>",
"    ]. According to some investigators, this is in contrast to typical HUS, which tends to have glomerular not arteriolar involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atypical HUS is a rare disorder with an estimated prevalence of 7 per one million children in Europe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INFECTION-INDUCED ATYPICAL HUS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Streptococcus pneumoniae",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumococcal-associated hemolytic-uremic syndrome (HUS) is the most common form of atypical HUS. In a retrospective study from seven tertiary centers in the United Kingdom, 43 of the 315 cases (14 percent) of HUS diagnosed between 1998 and 2005 were associated with pneumococcal infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/10\">",
"     10",
"    </a>",
"    ]. A higher rate was reported in a Canadian survey limited to atypical nondiarrheal HUS in which 9 of 27 cases was due to pneumococcal infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23143?source=see_link\">",
"     \"Microbiology and pathogenesis of Streptococcus pneumoniae\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the pathogenesis of pneumococcal associated-HUS is uncertain, it has been proposed that neuraminidase released during pneumococcal infection might play an important role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/11\">",
"     11",
"    </a>",
"    ]. Neuraminidase cleaves sialic acid on the cell glycocalyx, resulting in the exposure of the Thomsen-Friedenreich antigen (T antigen) on red blood cells, platelets, and glomeruli. The T antigen is recognized by a natural IgM antibody, a normal plasma constituent, which leads to polyagglutination of patients' red cells and hemolysis.",
"   </p>",
"   <p>",
"    However, two observations argue against an important role for the T antigen. First, the IgM is a cold antibody and is therefore unlikely to cause agglutination in vivo. Second, T antigen can be detected in approximately half of children with invasive pneumococcal disease without HUS and is not found in children with pneumococcal associated-HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical course of pneumococcal-associated HUS is illustrated by two case series.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the previously mentioned study from the United Kingdom, the following findings were noted in the 43 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/10\">",
"       10",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The median age at presentation was 13 months.",
"     </li>",
"     <li>",
"      In this cohort, there were 35 cases of pneumonia and 13 cases of meningitis including nine confirmed and four suspected cases. Pneumococcal infection was confirmed in 34 cases by blood cultures (n = 22), cerebral spinal fluid (CSF, n = 5), pleural fluid (n = 4), or by a positive RNA polymerase study or urinary pneumococcal antigen test. Empyema was present in 23 of 35 pneumonia cases.",
"     </li>",
"     <li>",
"      In twelve of the patients, serotyping was performed. Only 2 of the identifiable 12 strains were included in the pneumococcal conjugate vaccine (PC7). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/601?source=see_link&amp;anchor=H9889776#H9889776\">",
"       \"Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States\", section on 'Invasive disease caused by non-vaccine serotypes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dialysis therapy was required in 36 patients (84 percent).",
"     </li>",
"     <li>",
"      Red blood cell and platelet transfusions were given in 34 and 32 patients, respectively.",
"     </li>",
"     <li>",
"      Five patients died, primarily due to the underlying infection (3 cases of meningitis, 1 case of sepsis, and 1 case of pulmonary emboli while on hemodialysis).",
"     </li>",
"     <li>",
"      Follow-up data on the 35 of 38 survivors at a mean of nine months (range 1 to 63 months) demonstrated proteinuria in 8 patients, hypertension in 5 patients, and a mean glomerular filtration rate of 90",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per m2 in 25 patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a second case series from the United States of 37 patients who presented with pneumococcal-associated HUS between 1997 and 2009, the following findings were noted [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/12\">",
"       12",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The median age at presentation was 2 years and 28 months.",
"     </li>",
"     <li>",
"      Pneumococcal infection was confirmed by a positive culture in 33 cases. Of the 29 patients with bacteremia, six also had positive cultures of CSF or pleural fluid.",
"     </li>",
"     <li>",
"      Among the 24 serotyped isolates, all but one were non-PCV7 serotypes but were included in the serotypes covered by the 13-valent vaccine.",
"     </li>",
"     <li>",
"      Dialysis therapy was required in 27 patients (73 percent). Over half of the patients required mechanical ventilation and chest tube placement or surgical-assisted thoracoscopic surgery.",
"     </li>",
"     <li>",
"      Among 30 patients with a median follow-up of six months, seven remained on dialysis replacement therapy, three had undergone renal transplantation, four had neurologic sequelae, and one died due to meningitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results demonstrate that the morbidity and mortality of HUS associated with pneumococcal infection is more severe than typical HUS. In addition, HUS appears to be associated with more serious systemic pneumococcal disease including pneumonia accompanied by empyema or meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/10,12,13\">",
"     10,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HUS or TTP has been observed in patients, including children, with human immunodeficiency virus (HIV) infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/14\">",
"     14",
"    </a>",
"    ]. The majority of affected patients progress to ESRD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     GENETIC FORMS OF HUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increasing number of genetic causes of hemolytic-uremic syndrome (HUS) have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/1\">",
"     1",
"    </a>",
"    ]. These include HUS resulting from deficiencies of complement components and Von Willebrand factor cleaving protease (ADAMTS13), and intracellular defects of vitamin B12 metabolism. There also are cases of unclear etiology that are associated with an autosomal recessive and autosomal dominant inheritance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Complement dysregulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the genes for complement proteins including C3, factors H, B, and I, and CD46 (previously known as membrane cofactor protein, MCP) are associated with atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/9\">",
"     9",
"    </a>",
"    ]. It is estimated that approximately 50 percent of cases of atypical HUS result from mutations in these genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These mutations result in dysregulation of the complement system that leads to excessive complement activation that result in endothelial damage.",
"   </p>",
"   <p>",
"    Studies have shown that the gene that is affected determines the clinical presentation and outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. For example, patients with mutations of the gene for factor H have a poor prognosis because most percentage of these patients progress to ESRD or death within the first year of presentation. By contrast, few patients harboring mutations that affect MCP progress to ESRD, although relapse is common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/18\">",
"     18",
"    </a>",
"    ]. We discuss each of these affected genes below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Factor H deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon a candidate gene approach, linkage analysis in three families found that HUS segregated with a genetic locus at chromosome 1q32, the location for the genes encoding the family of complement regulatory proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/19\">",
"     19",
"    </a>",
"    ]. Further evaluation found that mutations in the gene for factor H, a serum complement regulatory protease, segregate with both autosomal recessive and dominant disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/19-25\">",
"     19-25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10854?source=see_link\">",
"     \"Regulators and receptors of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HUS associated with factor H deficiency usually presents during infancy or early childhood, but some cases are first observed in adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/19-21,26-29\">",
"     19-21,26-29",
"    </a>",
"    ]. The disease either may be sporadic or clearly associated with a family history of disease.",
"   </p>",
"   <p>",
"    Hemolytic anemia is marked at disease onset and during relapses, with haptoglobin levels remaining low during the course of the disease. Hypertension is frequently severe.",
"   </p>",
"   <p>",
"    The clinical and laboratory features were reported for 15 cases with either heterozygous or homozygous factor H deficiencies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/25\">",
"     25",
"    </a>",
"    ]. Among the six patients with homozygous deficiencies, two had HUS, with the remainder presenting with membranoproliferative glomerulonephritis; by comparison, 8 of 9 with a heterozygous mutation presented with HUS. With homozygotes, the age of onset of disease varied from 7 months to 10 years of age, while the onset for those with heterozygous defects ranged from 4 months to 34 years. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=see_link\">",
"     \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Laboratory values varied with the different defects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With homozygous mutations, all patients had markedly low levels of factor H antigen (all less than 1 percent [normal 70 to 130 percent]), C3 (range of less than 40 to 170",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [normal of 660 to 1250",
"      <span class=\"nowrap\">",
"       mg/dL]),",
"      </span>",
"      factor B (range of 17 to 70",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      [normal 90 to 320",
"      <span class=\"nowrap\">",
"       mg/L]),",
"      </span>",
"      and CH50 (range of less than 10 to 24 [normal 70 to 130 percent]).",
"     </li>",
"     <li>",
"      By comparison, the same laboratory values for those with heterozygous mutations were low to normal. These include factor H antigen (30 to 55 percent [normal 70 to 130 percent]), C3 (240 to 834",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [normal of 660 to 1250",
"      <span class=\"nowrap\">",
"       mg/dL]),",
"      </span>",
"      factor B (55 to 250",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      [normal 90 to 320",
"      <span class=\"nowrap\">",
"       mg/L]),",
"      </span>",
"      and CH50 (59 to 124 percent [normal 70 to 130 percent]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, normal factor H and C3 levels do not exclude the presence of a factor H mutation, since many affected patients are heterozygous for the mutation and have normal or only slightly decreased plasma factor H levels, as well as normal C3 levels. In this setting, we perform genetic or, in familial cases, linkage analysis to better characterize patients suspected of having an underlying factor H defect.",
"   </p>",
"   <p>",
"    The outcome after transplantation is associated with a high risk of recurrence (45 to 100 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/20,30,31\">",
"     20,30,31",
"    </a>",
"    ]. Consideration must be given to the possible presence of a factor H mutation in a potential living donor.",
"   </p>",
"   <p>",
"    There have been at least six cases of combined kidney and liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One case had fatal primary nonfunction of the liver allograft [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/32\">",
"       32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Another case was associated with long-term survival (two years post-transplant) with excellent function of both transplanted organs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third child had irreversible liver failure at one month post-transplant, which required repeat liver transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two children underwent successful liver-kidney transplantation in combination with pre- and perioperative plasma exchange [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A common feature among those with successful kidney-liver or kidney transplantation involved the use of extensive plasma exchange [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/36\">",
"     36",
"    </a>",
"    ]. Further experience is needed to better clarify the effectiveness of this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     CD46 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in another complement regulatory protein, CD46, previously known as membrane cofactor protein (MCP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/37\">",
"     37",
"    </a>",
"    ], have also been implicated in familial HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/17,38-40\">",
"     17,38-40",
"    </a>",
"    ]. This association was characterized in a study of 156 patients with atypical HUS, of whom 14 had mutations in MCP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/17\">",
"     17",
"    </a>",
"    ]. The aberrant proteins either resulted in decreased cell surface levels of MCP (most common) or an impaired ability to control alternative pathway complement activation on host cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/41\">",
"     41",
"    </a>",
"    ]. The disease was characterized by onset in early childhood, lack of progression to ESRD in most patients, incomplete penetrance, and a low rate of recurrence in the renal allograft (only one of five kidney transplants).",
"   </p>",
"   <p>",
"    These findings are consistent with other series, particularly the low rate of recurrence in the transplanted kidney and incomplete penetrance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Given the transplant result in those with MCP mutations and the high risk of recurrence in those with factor H mutations who receive a renal allograft, consideration should be given to determining the genetic defect in selecting transplant candidates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Complement factor I deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in complement factor I, the cofactor for MCP and factor H, are associated with atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In one study, 2 of 76 patients with HUS had defects in the gene for complement factor I, resulting in reduced serum protein levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/42\">",
"     42",
"    </a>",
"    ]. As observed in patients with defects in factor H, recurrent HUS was noted after kidney transplantation in both affected individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     C3 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;C3 mutations resulting in persistently low C3 levels have been identified in patients with atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. In one study, nine novel C3 mutations were identified in 14 patients with a mean age at presentation of 6.5 years (range 8 months to 40 years). Seven of the 14 patients regained function after their initial presentation and four of these patients had recurrent disease. Among the 14 patients, there have been 12 renal transplantations, five of which have had recurrent disease. Functional studies of seven of the nine mutations demonstrated five gain of function mutations and two inactivating mutations. In a second report from some of the same investigators, 14 patients had a gain in function mutation, R139W, in the C3 gene that resulted in a hyperactive C3 convertase with an increased affinity for factor B and reduced binding to CD46 protein (MCP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/45\">",
"     45",
"    </a>",
"    ]. In addition, there was an increase in the incidence of at-risk factor H and MCP haplotypes for HUS in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Complement factor B gain of function mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional mutations of complement factor B that either enhance the formation or delay the inactivation of C3bBb convertase have been reported in 1 to 3 percent of cases of atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Thrombomodulin mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 152 patients with atypical HUS, seven patients had six different mutations of the THBD gene, which encodes thrombomodulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/48\">",
"     48",
"    </a>",
"    ]. In vitro studies demonstrated that these mutations resulted in dysregulation of the complement system, which may lead to excessive complement activation, as they were less effective than normal thrombomodulin in converting C3b to its inactive form C3b. Thrombomodulin is a co-factor in the thrombin-induced activation of protein C that suppresses thrombin generation and clot formation, and plasma procarboxypeptidase B, a fibrinolysis inhibitor and inactivator of the anaphylatoxin C3a and C3b.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma exchange and infusion has generally been the first-line therapy for patients during the acute episode of atypical HUS. The response to plasma treatment appears to vary depending upon the affected complement component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/17\">",
"     17",
"    </a>",
"    ]. In patients with either factor H or factor I deficiencies, about two-thirds of patients will remit with plasma therapy. In contrast, there has been no difference in remission rates with or without plasma therapy in patients with MCP deficiency.",
"   </p>",
"   <p>",
"    Patients with mutations in genes for factor H, factor I, or C3 who fail to respond to plasma therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    have recurrent disease are likely to progress to ESRD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/17\">",
"     17",
"    </a>",
"    ]. It is unclear whether renal transplantation is an appropriate intervention in these patients, because recurrence of disease occurs in 50 percent of the transplanted kidney, and graft failure occurs in 90 percent of those with recurrent disease. Consideration must be given to the possible presence of the same mutation in a potential living donor.",
"   </p>",
"   <p>",
"    In 2007, a consensus conference recommended a combined liver-renal transplantations in atypical HUS cases in which renal transplantation is extremely unlikely to succeed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/49\">",
"     49",
"    </a>",
"    ]. This would include patients with factor H or I deficiency who have lost an isolated kidney transplant due to disease recurrence or have a family member with the same gene mutation who lost a kidney transplant due to disease recurrence. However, there are currently insufficient data to recommend combined liver-renal transplantation in patients with atypical HUS due to inherited complement dysregulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181861875\">",
"    <span class=\"h4\">",
"     Eculizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports have demonstrated that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"     eculizumab",
"    </a>",
"    , a monoclonal antibody to C5, is effective in the treatment of atypical HUS and prevents a relapse after transplantation by inhibiting complement activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/50-55\">",
"     50-55",
"    </a>",
"    ]. Eculizumab binds to complement protein C5, thus preventing the production of the terminal complement components C5a and the membrane attack complex C5b-9.",
"   </p>",
"   <p>",
"    In September 2011, the United States Food and Drug Administration (FDA) granted accelerated approval for the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"     eculizumab",
"    </a>",
"    for the treatment of atypical HUS based on their review of several case series that demonstrated its effectiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of 17 pediatric and adult patients with atypical HUS who were refractory to plasma therapy, four of five patients who required dialysis were able to discontinue dialysis therapy while receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"       eculizumab",
"      </a>",
"      . In nine patients, there was an improvement in renal function with an increase of at least 15",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      in the estimated glomerular filtration rate (eGFR). Normal platelet counts and lactate dehydrogenase (LDH) levels were achieved and maintained in 13 patients during the duration of therapy.",
"     </li>",
"     <li>",
"      In the second prospective case series of 20 patients with atypical HUS who were maintained on plasma therapy, administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"       eculizumab",
"      </a>",
"      was associated with a discontinuation of plasma therapy, the normalization of hematological parameters in 18 of the 20 patients, and stabilization of renal function. In a retrospective study of 19 children with atypical HUS, four of eight children who required dialysis were able to discontinue dialysis therapy. Seven patients had improved renal function with an increase in eGFR of at least 15",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m",
"      <sup>",
"       2",
"      </sup>",
"      . Eight patients achieved and maintained normal hematological status.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Induction dosing of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"     eculizumab",
"    </a>",
"    is based on patient body weight as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/58\">",
"     58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      5 to &lt;10 kg &ndash; 300 mg, one weekly dose",
"     </li>",
"     <li>",
"      10 to &lt;20 kg &ndash; 600 mg, one weekly dose",
"     </li>",
"     <li>",
"      20 to &lt;30 kg &ndash; 600 mg, two weekly doses",
"     </li>",
"     <li>",
"      30 to &lt;40 kg &ndash; 600 mg, two weekly doses",
"     </li>",
"     <li>",
"      &ge;40 kg &ndash; 900 mg, four weekly doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Maintenance dosing based on patient body weight as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      5 to &lt;10 kg &ndash; 300 mg every three weeks, starting week 2",
"     </li>",
"     <li>",
"      10 to &lt;20 kg &ndash; 300 mg every two weeks, starting week 2",
"     </li>",
"     <li>",
"      20 to &lt;30 kg &ndash; 600 mg every two weeks, starting week 3",
"     </li>",
"     <li>",
"      30 to &lt;40 kg &ndash; 900 mg every two weeks, starting week 3",
"     </li>",
"     <li>",
"      &ge;40 kg &ndash; 1200 mg every two weeks, starting week 5",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of note, the doses for young children were calculated from a pharmacokinetic model derived from adult data because there are no data in children. In some children, the above dosing protocol has not completely blocked complement activation, and in these patients, dosing of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"     eculizumab",
"    </a>",
"    has been increased. If eculizumab is used in young children, complement activity should be assessed by measuring CH50. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview and clinical assessment of the complement system\", section on 'CH50'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"     eculizumab",
"    </a>",
"    is associated with life-threatening and fatal meningococcal infections. To mitigate this risk, a Risk Evaluation and Mitigation Strategy (REMS) has been developed. Health care providers are required to enroll in a registration program, certify that they will counsel and provide educational materials to patients about the risks of eculizumab, and agree to promptly report cases of meningococcal infection. Enrollment in the REMS program and additional information are provided by the manufacturer (1-888-765-4747).",
"   </p>",
"   <p>",
"    Children treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/63/28662?source=see_link\">",
"     eculizumab",
"    </a>",
"    may also be at increased risk of developing serious infections due to Streptococcus pneumoniae and Haemophilus influenza type b. Patients should receive vaccinations for the prevention of these infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39818?source=see_link&amp;anchor=H48#H48\">",
"     \"Standard immunizations for children and adolescents\", section on 'Pneumococcal vaccine'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39818?source=see_link&amp;anchor=H20#H20\">",
"     \"Standard immunizations for children and adolescents\", section on 'Hib conjugate vaccine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Von Willebrand factor cleaving protease deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Von Willebrand factor (VWF), a glycoprotein that carries factor VIII in the circulation, is required for platelet adhesion and platelet aggregation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/59\">",
"     59",
"    </a>",
"    ]. Large multimers of VWF are more effective than dimers for platelet adhesion and platelet aggregation. When released from endothelial cells and platelets, these large multimers do not normally circulate because they are cleaved by a specific protease, a metalloprotease synthesized by the liver. This protease is the thirteenth member of the ADAMTS family, or ADAMTS13 (",
"    <strong>",
"     A",
"    </strong>",
"    &nbsp;",
"    <strong>",
"     D",
"    </strong>",
"    isintegrin-like",
"    <strong>",
"     A",
"    </strong>",
"    nd",
"    <strong>",
"     M",
"    </strong>",
"    etalloprotease with",
"    <strong>",
"     T",
"    </strong>",
"    hrombo",
"    <strong>",
"     S",
"    </strong>",
"    pondin type 1 repeats) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many cases of adult thrombotic thrombocytopenic purpura (TTP) are due to deficient activity of the VWF cleaving protease. Protease deficiency may be inherited by autosomal recessive transmission or may be induced by an acquired autoantibody that inhibits protease activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. A few cases of antibody-induced VWF cleaving protease deficiency have been reported in children aged 1 to 11 years who presented with symptoms of TTP.",
"   </p>",
"   <p>",
"    VWF cleaving protease deficiency related to mutations in the ADAMTS13 gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/64\">",
"     64",
"    </a>",
"    ]. Whether or not these are cases of TTP or atypical HUS is unclear, as it is sometimes difficult to distinguish between the two disorders. Most affected children presented at birth with hemolytic anemia and thrombocytopenia. Renal involvement often occurs later in life and has a progressive course. Onset of disease up to five years of age has also been reported. Many develop symptoms of CNS involvement.",
"   </p>",
"   <p>",
"    Absolute VWF cleaving protease deficiency has also been reported in an adult with concomitant factor H gene mutation, who had severe manifestations of TTP including renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Defects of vitamin B12 metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin B12 or cobalamin is the coenzyme of methionine-synthase (or methyl-transferase), which transforms homocysteine in methionine. It is also the coenzyme of methylmalonyl-CoA mutase, which is involved in the conversion of methylmalonyl CoA to succinyl-CoA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/66\">",
"     66",
"    </a>",
"    ]. Children affected with cobalamin C mutations have a functional defect of both methylmalonyl CoA mutase and methionine-synthase. This defect results in methylmalonic acidemia with homocystinuria.",
"   </p>",
"   <p>",
"    Approximately 25 percent of reported cases also have atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/66\">",
"     66",
"    </a>",
"    ]. The first symptoms, which are nonspecific, occur in the neonatal period and consist of anorexia, vomiting, failure to thrive, hypotonia, seizures, and lethargy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. The first symptoms and signs of HUS are observed between the end of the first month and three months of age:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe hemolytic anemia with schistocytes, which is accompanied by macrocytosis.",
"     </li>",
"     <li>",
"      Frequent thrombocytopenia",
"     </li>",
"     <li>",
"      Renal involvement characterized by hematuria, proteinuria, renal dysfunction of variable severity, and hypertension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Amino acid and organic acid chromatography reveal a marked increase of homocysteine and a low level of methionine in the plasma, while urinary excretion of homocysteine and methylmalonic acid is very high. Therapy should be started as soon as possible, with the prognosis related to the precocity of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Idiopathic autosomal recessive disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic autosomal recessive HUS is mainly observed in children, with the onset of disease occurring from the neonatal period to adult life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Although not universal, affected siblings of a given family develop HUS at a similar age.",
"   </p>",
"   <p>",
"    In general, autosomal recessive disease has a gradual onset, often with isolated hemolytic anemia. The prognosis is poor, with the majority of patients progressing to ESRD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Idiopathic autosomal dominant disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic autosomal dominant HUS is less frequently observed than autosomal recessive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/71\">",
"     71",
"    </a>",
"    ]. The onset of HUS typically occurs at different ages in members of the same family. Although it is usually observed in adults, autosomal dominant HUS may begin in childhood. Eighteen cases have been reported with an onset between 5 months and 17 years of age.",
"   </p>",
"   <p>",
"    The onset of autosomal dominant HUS is gradual, without a prodromal phase. Relapses may occur, but they appear to be less frequent than in the autosomal recessive form or in atypical sporadic cases. The outcome is most often poor, with ESRD being observed in more than 90 percent of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OTHER CAUSES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug-induced hemolytic-uremic syndrome (HUS) has been observed in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among transplant patients treated with either",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/24/34176?source=see_link\">",
"       cyclosporine",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/53/34640?source=see_link\">",
"       tacrolimus",
"      </a>",
"      . It usually occurs during the first few months post-transplantation, a time when high doses of calcineurin inhibitors are being administered.",
"     </li>",
"     <li>",
"      During treatments with cytotoxic drugs, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/16/38144?source=see_link\">",
"       mitomycin",
"      </a>",
"      C,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?15/33/15895?source=see_link\">",
"       bleomycin",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/8/34949?source=see_link\">",
"       cisplatin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      With the administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/27/35255?source=see_link\">",
"       ticlopidine",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/12/19655?source=see_link\">",
"       quinine",
"      </a>",
"      , and oral contraceptives.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Idiopathic neonatal HUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic nondiarrheal HUS with onset in the neonatal period has also been observed. The nephropathy, with proteinuria and hematuria, often presents insidiously and has a relapsing course. Progression to renal failure occurs in 20 to 60 percent of children. Some children also develop CNS manifestations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Immunologic",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Complement antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Factor H antibodies have been reported in about 8 to 10 percent of patients with atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/72-76\">",
"     72-76",
"    </a>",
"    ]. This was illustrated in a study of the Newcastle cohort of 308 cases of atypical HUS that reported the presence of factor H antibodies in 13 of 142 patients screened for factor H antibodies (9.2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/76\">",
"     76",
"    </a>",
"    ]. Most of these patients have genetic mutations of complement proteins. In particular, absent copies of factor H-related proteins 1",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    3 were reported in about 80 to 90 percent of patients with factor H antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/72,74,76\">",
"     72,74,76",
"    </a>",
"    ]. Mutations in other complement genes (factor H, factor I, CD46, factor B and C3) also were identified in a minority of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/76\">",
"     76",
"    </a>",
"    ]. These findings suggest that in some cases of atypical HUS, multiple \"hits\" to the complement system may be necessary for the pathogenesis of atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/76,77\">",
"     76,77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the range of different therapeutic interventions that have been used to treat patients with atypical HUS due to factor H antibodies, it is difficult to assess the efficacy of any specific regimen. However, it appears that plasma exchange plus immunosuppressive therapy have been successful measures in some patients with factor H antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/72-74,76\">",
"     72-74,76",
"    </a>",
"    ]. In contrast, treatment with intravenous immunoglobulin (IVIG) does not appear to be beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Outcome varies as demonstrated by the following case series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest case series, outcome data at a mean follow-up of 39 months were available for 44 of the 45 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/72\">",
"       72",
"      </a>",
"      ]. Four patients died (unknown cause in two patients, one from pulmonary arterial hypertension, and one from cardiac disease), 25 patients had relapses, 17 developed chronic renal disease including 12 who went on to ESRD, and 11 patients had no sequelae.",
"     </li>",
"     <li>",
"      In the Newcastle study, 7 of the 13 patients regained renal function; two patients required prophylactic long-term plasma exchange, and one has been successfully treated with plasma exchange during three relapses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/76\">",
"       76",
"      </a>",
"      ]. The other six patients progressed to ESRD, three of whom had received renal transplantation without recurrence of disease (range of follow-up two to six years).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A small case series reported that",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/62/38886?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    pulse therapy resulted in a prolonged decrease of complement factor H antibody titers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;HUS has been observed in children with systemic lupus erythematosus as well as in those with a catastrophic antiphospholipid syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=see_link\">",
"     \"Clinical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35287?source=see_link\">",
"     \"Antiphospholipid syndrome and the kidney\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of microangiopathic hemolytic anemia, renal failure, and thrombocytopenia in the patient without a prodromal history of diarrhea defines atypical hemolytic-uremic syndrome (HUS). If thrombocytopenia is not limiting, a renal biopsy can be helpful in patients without a clear diagnosis, although the need for a diagnostic renal biopsy in HUS is exceptional. The renal biopsy should reveal a thrombotic microangiopathy, primarily involving the arterioles.",
"   </p>",
"   <p>",
"    Although many cases of atypical HUS are idiopathic, some children have a known associated condition or cause of disease.",
"   </p>",
"   <p>",
"    The following causes and diagnostic testing should be considered in any patient who presents with atypical HUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atypical HUS may occur as a complication of Streptococcus pneumoniae infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Streptococcus pneumoniae'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/42/12970?source=see_link&amp;anchor=H8#H8\">",
"       \"Pneumococcal meningitis in children\", section on 'Complications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35001?source=see_link&amp;anchor=H7#H7\">",
"       \"Pneumococcal pneumonia in children\", section on 'Complications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Genetic forms of HUS should be screened in all patients who present with atypical HUS as a diagnosis of a underlying genetic form of HUS may impact on management decisions. In particular, serum levels of C3, C4, and factors H and I, CD43 expression, and ADAMTS13 activity should be measured [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/9,79\">",
"       9,79",
"      </a>",
"      ]. Confirmatory genetic testing and screening for autoantibodies to factor H should be considered in patients with a low complement protein level. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Complement dysregulation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24\">",
"       'Complement antibodies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An inborn error of vitamin B12 metabolism should be suspected in cases of neonatal onset with neurologic deterioration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/52/43849/abstract/4,80\">",
"       4,80",
"      </a>",
"      ]. Amino acid and organic acid chromatography reveal a marked increase in homocysteine and a low level of methionine in the plasma, while urinary excretion of homocysteine and methylmalonic acid is very high.",
"     </li>",
"     <li>",
"      Drug-induced HUS should be suspected in children with known exposure to a culprit agent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The constellation of clinical and laboratory findings of atypical HUS in children can be mimicked in certain other disorders. Other than those disorders associated with diarrhea, the differential diagnosis for typical and atypical HUS is similar. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/55/35704?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atypical hemolytic-uremic syndrome (HUS) is defined by the characteristic triad of HUS (microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure), but",
"    <strong>",
"     without",
"    </strong>",
"    a diarrheal prodrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atypical HUS is responsible for 10 percent of all HUS cases in children.",
"     </li>",
"     <li>",
"      Children with atypical HUS have a varied clinical presentation and course. Some children will present with acute renal failure similar to patients with typical HUS. Other patients with atypical disease may have an insidious onset but are at high risk of death, disease recurrence,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chronic renal disease. The remaining patients have less severe renal involvement with relatively good long-term outcomes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Atypical HUS is often associated with an underlying infection or a known genetic defect, or as an adverse drug effect. It is also likely that many idiopathic cases are due to an as yet uncharacterized genetic defect. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Infection-induced atypical HUS'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Genetic forms of HUS'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An increasing number of genetic causes of atypical HUS have been described. These include deficiencies of complement regulation and Von Willebrand factor cleaving protease (ADAMTS 13), and intracellular defects of vitamin B12 metabolism. There are also cases due to unknown defects that are clearly associated with an autosomal recessive and autosomal dominant mode of inheritance. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Genetic forms of HUS'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/1\">",
"      Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/2\">",
"      Siegler RL, Pavia AT, Hansen FL, et al. Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. J Pediatr 1996; 128:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/3\">",
"      Constantinescu AR, Bitzan M, Weiss LS, et al. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 2004; 43:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/4\">",
"      Fitzpatrick MM, Walters MD, Trompeter RS, et al. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr 1993; 122:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/5\">",
"      Kaplan BS. Hemolytic uremic syndrome with recurrent episodes: an important subset. Clin Nephrol 1977; 8:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/6\">",
"      Kaplan BS, Proesmans W. The hemolytic uremic syndrome of childhood and its variants. Semin Hematol 1987; 24:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/7\">",
"      Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994; 94:35.",
"     </a>",
"    </li>",
"    <li>",
"     Habib R. Pathology of the hemolytic uremic syndrome. In: Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura, Kaplan B, Trompeter R, Moake J (Eds), Marcel Dekker, New York 1992. p.315.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/9\">",
"      Taylor CM, Machin S, Wigmore SJ, et al. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 2010; 148:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/10\">",
"      Waters AM, Kerecuk L, Luk D, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007; 151:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/11\">",
"      Geary DF. Hemolytic uremic syndrome and streptococcus pneumoniae: improving our understanding. J Pediatr 2007; 151:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/12\">",
"      Banerjee R, Hersh AL, Newland J, et al. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J 2011; 30:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/13\">",
"      Bender JM, Ampofo K, Byington CL, et al. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J 2010; 29:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/14\">",
"      Turner ME, Kher K, Rakusan T, et al. A typical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children. Pediatr Nephrol 1997; 11:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/15\">",
"      Noris M, Remuzzi G. Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management? Nat Clin Pract Nephrol 2005; 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/16\">",
"      Geerdink LM, Westra D, van Wijk JA, et al. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 2012; 27:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/17\">",
"      Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/18\">",
"      Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007; 18:2392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/19\">",
"      Warwicker P, Goodship TH, Donne RL, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998; 53:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/20\">",
"      Caprioli J, Bettinaglio P, Zipfel PF, et al. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001; 12:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/21\">",
"      Warwicker P, Donne RL, Goodship JA, et al. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant 1999; 14:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/22\">",
"      Rougier N, Kazatchkine MD, Rougier JP, et al. Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 1998; 9:2318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/23\">",
"      Noris M, Remuzzi G. Are HUS and TTP genetically determined? Kidney Int 1998; 53:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/24\">",
"      Warwicker P, Goodship JA, Goodship TH. Factor H--US? Nephrol Dial Transplant 1998; 13:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/25\">",
"      Dragon-Durey MA, Fr&eacute;meaux-Bacchi V, Loirat C, et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 2004; 15:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/26\">",
"      Ohali M, Shalev H, Schlesinger M, et al. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol 1998; 12:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/27\">",
"      Landau D, Shalev H, Levy-Finer G, et al. Familial hemolytic uremic syndrome associated with complement factor H deficiency. J Pediatr 2001; 138:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/28\">",
"      Vaziri-Sani F, Holmberg L, Sj&ouml;holm AG, et al. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 2006; 69:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/29\">",
"      St&aring;hl AL, Vaziri-Sani F, Heinen S, et al. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood 2008; 111:5307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/30\">",
"      Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 2003; 18:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/31\">",
"      Zuber J, Le Quintrec M, Sberro-Soussan R, et al. New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol 2011; 7:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/32\">",
"      Remuzzi G, Ruggenenti P, Colledan M, et al. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation. Am J Transplant 2005; 5:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/33\">",
"      Saland JM, Emre SH, Shneider BL, et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 2006; 6:1948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/34\">",
"      Remuzzi G, Ruggenenti P, Codazzi D, et al. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 2002; 359:1671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/35\">",
"      Jalanko H, Peltonen S, Koskinen A, et al. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 2008; 8:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/36\">",
"      Davin JC, Strain L, Goodship TH. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatr Nephrol 2008; 23:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/37\">",
"      Post TW, Liszewski MK, Adams EM, et al. Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 1991; 174:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/38\">",
"      Noris M, Brioschi S, Caprioli J, et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003; 362:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/39\">",
"      Richards A, Kemp EJ, Liszewski MK, et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003; 100:12966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/40\">",
"      Fremeaux-Bacchi V, Moulton EA, Kavanagh D, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006; 17:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/41\">",
"      Fang CJ, Fremeaux-Bacchi V, Liszewski MK, et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008; 111:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/42\">",
"      Kavanagh D, Kemp EJ, Mayland E, et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:2150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/43\">",
"      Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004; 41:e84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/44\">",
"      Fr&eacute;meaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008; 112:4948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/45\">",
"      Roumenina LT, Frimat M, Miller EC, et al. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 2012; 119:4182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/46\">",
"      Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2007; 104:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/47\">",
"      Roumenina LT, Jablonski M, Hue C, et al. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood 2009; 114:2837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/48\">",
"      Delvaeye M, Noris M, De Vriese A, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/49\">",
"      Saland JM, Ruggenenti P, Remuzzi G, Consensus Study Group. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2009; 20:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/50\">",
"      Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med 2009; 360:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/51\">",
"      N&uuml;rnberger J, Philipp T, Witzke O, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med 2009; 360:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/52\">",
"      Zimmerhackl LB, Hofer J, Cortina G, et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 2010; 362:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/53\">",
"      Lapeyraque AL, Fr&eacute;meaux-Bacchi V, Robitaille P. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome. Pediatr Nephrol 2011; 26:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/54\">",
"      Prescott HC, Wu HM, Cataland SR, Baiocchi RA. Eculizumab therapy in an adult with plasma exchange-refractory atypical hemolytic uremic syndrome. Am J Hematol 2010; 85:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/55\">",
"      Al-Akash SI, Almond PS, Savell VH Jr, et al. Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr Nephrol 2011; 26:613.",
"     </a>",
"    </li>",
"    <li>",
"     FDA approval for eculizumab in the treatment of atypical hemolytic uremic syndrome. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm272990.htm (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     ASCO update on FDA approval of eculizumab for atypical hemolytic uremic syndrome. file://view.broadcastemail.asco.org/?j=fe5b16777c66037d7c14&amp;m=fefc1574706d04&amp;ls=fdcb1571736504787611727063&amp;l=fe5815777163027f711c&amp;s=fe241670736401757c1d74&amp;jb=ffcf14&amp;ju=fe3b17727565057e771c70 (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     Dosing of Eculizumab in pediatric atyical hemolytic uremic syndrome. file://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125166s172lbl.pdf (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/59\">",
"      Furlan M. Von Willebrand factor: molecular size and functional activity. Ann Hematol 1996; 72:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/60\">",
"      Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/61\">",
"      Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/62\">",
"      Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/63\">",
"      Remuzzi G, Galbusera M, Noris M, et al. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 2002; 100:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/64\">",
"      Veyradier A, Obert B, Haddad E, et al. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr 2003; 142:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/65\">",
"      Noris M, Bucchioni S, Galbusera M, et al. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. J Am Soc Nephrol 2005; 16:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/66\">",
"      Ogier de Baulny H, G&eacute;rard M, Saudubray JM, Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 1998; 157 Suppl 2:S77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/67\">",
"      Kind T, Levy J, Lee M, et al. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol 2002; 24:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/68\">",
"      Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 2007; 22:2097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/69\">",
"      Niaudet P, Gagnadoux MF, Broyer M, Salomon R. Hemolytic-uremic syndrome: hereditary forms and forms associated with hereditary diseases. Adv Nephrol Necker Hosp 2000; 30:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/70\">",
"      Kaplan BS, Meyers KE, Schulman SL. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 1998; 9:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/71\">",
"      Kaplan BS, Leonard MB. Autosomal dominant hemolytic uremic syndrome: variable phenotypes and transplant results. Pediatr Nephrol 2000; 14:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/72\">",
"      Dragon-Durey MA, Sethi SK, Bagga A, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol 2010; 21:2180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/73\">",
"      J&oacute;zsi M, Strobel S, Dahse HM, et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 2007; 110:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/74\">",
"      J&oacute;zsi M, Licht C, Strobel S, et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 2008; 111:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/75\">",
"      Abarrategui-Garrido C, Mart&iacute;nez-Barricarte R, L&oacute;pez-Trascasa M, et al. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 2009; 114:4261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/76\">",
"      Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010; 115:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/77\">",
"      Rodr&iacute;guez de C&oacute;rdoba S. aHUS: a disorder with many risk factors. Blood 2010; 115:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/78\">",
"      Boyer O, Balzamo E, Charbit M, et al. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies. Am J Kidney Dis 2010; 55:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/79\">",
"      Kavanagh D, Richards A, Fremeaux-Bacchi V, et al. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2007; 2:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/52/43849/abstract/80\">",
"      Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Child 1997; 76:518.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6084 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-201.211.0.116-6B7F8F4AE5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43849=[""].join("\n");
var outline_f42_52_43849=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INFECTION-INDUCED ATYPICAL HUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Streptococcus pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      GENETIC FORMS OF HUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Complement dysregulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Factor H deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - CD46 deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Complement factor I deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - C3 mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Complement factor B gain of function mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Thrombomodulin mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H181861875\">",
"      Eculizumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Von Willebrand factor cleaving protease deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Defects of vitamin B12 metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Idiopathic autosomal recessive disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Idiopathic autosomal dominant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OTHER CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Idiopathic neonatal HUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Immunologic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Complement antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35287?source=related_link\">",
"      Antiphospholipid syndrome and the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/55/35704?source=related_link\">",
"      Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=related_link\">",
"      Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/601?source=related_link\">",
"      Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23143?source=related_link\">",
"      Microbiology and pathogenesis of Streptococcus pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=related_link\">",
"      Overview and clinical assessment of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/42/12970?source=related_link\">",
"      Pneumococcal meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35001?source=related_link\">",
"      Pneumococcal pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10854?source=related_link\">",
"      Regulators and receptors of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/59/30649?source=related_link\">",
"      Treatment and prognosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_52_43850="Basic case 12";
var content_f42_52_43850=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60739&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60739&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1272px;\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Basic case 12",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43850=[""].join("\n");
var outline_f42_52_43850=null;
var title_f42_52_43851="Risk factors for intracranial hemorrhage with thrombolysis";
var content_f42_52_43851=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cooperative cardiovascular project risk model for intracranial hemorrhage with thrombolytic therapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"        Risk",
"Factors*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Age &ge;75 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Black race",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Female sex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Prior history of stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Systolic blood pressure",
"      &ge;160 mmHg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Weight &le;65 kg for women or &le;80 kg for men",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        INR &gt;4 or PT",
"&gt;24&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Use of alteplase",
"(versus other thrombolytic agent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Risk score",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Rate of intracranial",
"hemorrhage, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 or 1",
"       </td>",
"       <td>",
"        0.69",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1.02",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1.63",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        2.49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;5",
"       </td>",
"       <td>",
"        4.11",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Each risk factor is worth 1 point if present, 0 points if absent. Points are added to determine the risk score.",
"     <br>",
"      &bull; INR: international normalized ratio; PT: prothrombin time.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from Brass LM, Lichtman JH, Wang Y, et al. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the cooperative cardiovascular project. Stroke 2000; 31:1802.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43851=[""].join("\n");
var outline_f42_52_43851=null;
var title_f42_52_43852="Homesickness prevention tips for hospital staff";
var content_f42_52_43852=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Homesickness-prevention strategies for hospital staff members working with children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       1. Coach parents before admission not to  deceive their child about the purpose and timing of hospitalization. Although the honest truth may be upsetting or startling to some children, coping with the reality of their situation now prevents uncomfortable surprises later. Children who feel \"tricked\" into hospitalization lose confidence in the reliability of their caregivers and therapists, and this both increases homesickness and lessens trust.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Orientation to the unit is one key to good adjustment. When children feel as if they have some control over the novel hospital environment, they may be less fearful and homesick. Depending on the child's condition, a tour of the unit, labeled photographs of staff members, big calendars, daily schedules, and introductions to the other kids on the unit can all help children feel comfortable and oriented in their new environment.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3. When possible, staff members should convey a consistent message about length of stay. Conflicting messages from adults in charge reduces children's global confidence in caregivers. Unpredictability leads to anxiety. If one staff member says, \"You'll be here about two weeks,\" and another says, \"You'll be here about three weeks,\" children are likely to feel distressed and homesick.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4. When hospitalization follows a traumatic event in which multiple family members were involved, family members may be in different parts of the hospital or even different hospitals. This can induce homesickness and separation anxiety. When possible, staff members should help children make contact, by telephone or in person, with dispersed family members.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5. A child's mental status during hospitalization can change dramatically, even in the course of a day. Often, these changes involve a distorted sense of time and a fluctuating awareness of the caregivers' presence. These factors can cause homesickness. Continue efforts to orient the child. Pictures of the family, large clocks and calendars, lights on in rooms during the day, and frequent reminders often help reorient homesick children.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6. Changes and uncertainties in caregiver visitations can cause homesickness. Caregivers should be apprised of the importance of frequent, reliable contact with their children. Staff members should encourage caregivers to call and give ample warning if they are unable to make a scheduled visit.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       7. Sometimes hospitalized children feel left alone, and this can cause homesickness. Especially early in a hospital stay, before the child knows the staff and routine, even five minutes alone can be frightening. Try to keep children apprised of the day's schedule, and give ample warning if there are going to be times when the child is left alone, however briefly.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       8. To ease parental separation anxiety, staff members should forewarn parents when their child will be moved to a different room. Parents are unsettled to come to visiting hours and enter their child's room, only to find it empty or occupied by a stranger. For the same reasons that children need to feel prepared for upcoming events, so do parents.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       9. When possible, minimize discharge uncertainty. Children have an easier time coping with homesickness when they have a fixed-length hospital stay to manage. By the same token, avoid changing a child's discharge date if at all possible. Once staff members state an exact date out loud, children (and parents) have a tendency to fixate on that date. Changing the promised date can provoke homesickness. It may be best to tell children and families that discharge dates are hard to predict and to give them a range of plausible dates.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Thurber CA, Walton E, the Council on School Health. Preventing and treating homesickness. Pediatrics 2007; 119:192. Copyright &copy; 2007 by the AAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43852=[""].join("\n");
var outline_f42_52_43852=null;
var title_f42_52_43853="Norepinephrine in HF";
var content_f42_52_43853=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plasma norepinephrine and survival in HF",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 224px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Percent probability of survival in patients with advanced heart failure according to the plasma norepinephrine concentration. Survival was inversely related to the degree of norepinephrine activation, a presumed reflection of worsening cardiac function. The time to 50 percent survival was approximately 30 months in patients with normal norepinephrine levels (200 pg/mL) but only about 10 months in those with marked hypersecretion (1200 pg/mL).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Cohn JN, Levine TB, Olivaro MT, et al. N Engl J Med 1984; 311:819.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43853=[""].join("\n");
var outline_f42_52_43853=null;
var title_f42_52_43854="Ross River virus rash";
var content_f42_52_43854=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rash of Ross River virus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 236px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADsAWkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDqY9a1jIzq2o5x0N0/+NTjWNXGM6tqGP8Ar5f/ABqgDxjHFOdsgEYrxeeXc6bFv+29YBONV1A46n7Q/wDjQdc1fbn+1b/k/wDPw/8AjVDJb2HtTmDEjpgdKXPLuXZFttb1jk/2tfjPTFy/+NNXW9ZOD/a1/gdf9JfP86qvz1PA6io2OeB0o55dytDQl1zVycjVdQHHAFy4/rUba5rIyf7W1Ek/9PL/AONUSeOvHrTNwK8dO3NPml3BJdi42vazncNX1H6fan/xpV17WQMnV9RJ9PtL/wCNUCu0YzmmO4U46k0c0u5dk+hffxBrXT+19R+v2lxn9aj/ALd1xuRrOognoPtT/wCNVVGQNwyaU4UZx7UueXcenYsjXtbVudY1I4/6en/xpreINbJO3WNRx0z9qfg/nVEgcgk0pRWGRjHpT5pdxtJFn+39dbprOpYH/T1Jz+tI2v66Gx/bOp/+BUn+NRHbsGMZ9u1QlcfNjr+lHPIFY0h4h1nH/IY1Ljp/pL8/rSf2/rQODrGpD/t6k/xrNyCuB0BpdgGSeeP1o5pdyWkaD6/rmMjWdS9v9Kf/ABqr/wAJHrpfb/bWpj/t6k/xquRgc1DIg3bvSqUpdxxSL58Q67k7da1P2H2qT/GoX8Ra8Dg63qn/AIFv/jVOSQKFCjkVXlOE3HP4U1KXcfKuxdl8Ta+rY/t3VBk8f6XJ/jSHxNr+Rt1zVQPT7XIc/rWaw3kce+CaxfE+pNpmlPImRM52Rk+p7/hVJyelwailcTxZ8S/EFqzWmn67qhmHDuLyT5fYc9a4KX4h+NXZv+Ks8QKfRdRmGP8Ax6qUFrJfzuqMvqzOwA68kn8a6XW/CWj6DpEtxe6vFc6gfljtYF7gZy2eQMEYPeumL5dDkck3sU4viR4tmQKde14yZHzJqtx0A5434561raf4v+IFvPCz61rn74Dy/tGozbWB78sRXJadcxfZneREilbmOSJiHHGMY6YqsL65tbhYr2SaSLIKkseB9KvUh6nqyfGPxdprebczrcqIwzRm9kBGTjuevtXnes/FDxhe300sHifXbWNmysUWpTAD2HzVHeakbnTbtIzOzyDLtuLbhnPPtzXLs1skLq0LNKWBV93AGOQR9acVZiN+X4i+NkZd3i/xF0B41Sbp/wB9dasJ8RfGUkYx4v8AEIYdD/ac3I9/mrjzGGIPBzUkQ2kZ6Hiqb0KWjPUNC+IPiy8j2v4n1wuvBP2+X/4qtn/hLvFmM/8ACTa2R/1/y/8AxVea+FgReFRzxXbIMAZ7dMVjK50K1zX/AOEv8UgAnxLrmP8Ar/l/+KqN/Gfik5C+JdbyP+n+X/4qs8rvGOcdarumD7etRdjsjUbxn4qU4/4SbW/r9vl/+KqJ/Gnis/8AMza4B7X8v/xVZm1eSQM1C6jr3PQU7sLI1z408V858Ua4AP8AqIS//FVGfG3izGR4n17/AMGEv/xVY4XJzjp19qQoMceuevWi7DlRsN428W7c/wDCT67/AODCb/4qoj428Xf9DTrv/gwm/wDiqymBbPaodvXPWndk2RtHxv4uzx4p14/9xCX/AOKpn/Cb+LyCf+Ep17/wYTf/ABVYxUHimkccUXYmjZbxz4uH/M1a8P8AuIzf/FUn/Cd+Lv8Aoate/wDBjN/8VWC68E5yTUX4UXYmkfSrcoQvUc1GeelSkNkDGBjr3prAAY56155KIQMDg9e9G5gSSc/1qVotxIXFJtC0yrkUj8AYJ7mo2IxnHPrUsjfMfU1F/wAtMbcjrmgpDJjujwDioIk2suDnnvVpkyyhQSD1pp6ZA29qdyk9LDJRleDzn8aYcj5j07VIV+TJ6npmkZDIg4JoDUrsxRiRkDPJpfNLdcYNBT+EkAZpTHs2qegp6FEBba5JGQfWnqWHHIz6VJsHJ2nIHFPGA4C5Jx6UhtidAeDzUbKVHUYNWGToSQMmmhc4IOeelFyEVlByAB9Kex3LkDgdaXyzvwQMUpQhB6k9KB3IWcA8gcDAxUUh+TIHWpHUt0AOKR1JzjvzTKKkgJwwxuz+VMdMDqcmrSpuyQM9gKYy84HPaquO5RVGBz+Vcb8St4jsBnCksfx4rvWQcDPSuc8e6Yb3RleFcvCxYD2rSD1Iqao8/wBNt2v7We0tbTzpgvnNOWI8tVByoHQ/X2rNMzJBJatGrq5++fvDHv8A0qe1vGtLeaJYwXfox/h9auarpMcWh2d5AHLSErM+7IDYyv49eK6bnKc/5c9pvZEyp4EmMgVCkcl3JHDyWdwAepyeK2tKlv7SQyafcSwyDq6DqTxg+laGv6Ze6eLK7mWRLgkSguuAe4Oe9VzWC5f8IGw0LUdSsfECyBZLdo9qYBY8ZU56HiuU1axsm1Jo9LuCYGzj7QApT2JHH41vatcp4hvGurnZbW88hbzCMlWCjI+nArl72R2uXWeMLKDgmNdo4HpUre4ooLjT44WCbHaU8BUkV89PT61SijLSBMcd6mtzKSPIX95u3bxkEfStfTdKedxEoyert2+gqnKxpFF/wnaMGacjGTxXXQoMZ49aZZ2K20KxoBxgAAVbER+o+tZNmiRAFwQCOOtQyDPbjoKuMhA5FQvH8nA5pFFCRefl5X2qMqD1HSrTKVAHTnmmFC3f8aB2KbxHOQcikaMg8VcZDjoABTGCnpTFcpMOcCo5FGM96tlTkkDjHSoivqce1CAreWSetNZSOPWrQXk9h3NROCFwOc0AVJF6moatMMdQcVBtb/apBsfSRHTnhfwqN8ngkewqV+Byep6Ux8tnb6VwmSQgyqYHUmkfIXH/ANenqTsORz3NNYEAkcZ45pisQ/xD1x1pSuVx61KE4Cknr6UBSGBUbhnnPFA7kQQAHHFQsmc98d6syr97HQdPeolXnIOV70FIYyAY9O2e9KUAA/pUwByTtOQfxqPbt3emKLj1IJIw2MdCeaR48Dgcdvaph8pOcdO9MJb0+h7UFJsgZcKAOKULh+cZxyakIAGWHucUCPngA5oKuMyrPtPXG6lUdeDkVMoz0wKaVIzg8fTrTJuN8sZzUcigsOSNvQVOQQcGmkDBLCkCKrRgAjv35pjKA4UcinSShO6jJxUKHcTjGKo05Xa4rHB6ACoyD0GMn3qZ0YD27U0oS3vjgUxFYLlvcU8xLNA0bfdYYxUzRHAxwTQVCkDGKaYnZnm/iXwn++eRD5ZJ4bHyt9a5u60LVbeMIInlhX95+5PmAZ45x0Ne3Sqkke2RQwxWNc6EjMHt3Mf0rWNXuYSieKmCaMkTRyKQejAjpWz4q1ttY8iJExHFGqB9uGfA79a9Fu7LWSmz7bLImCNryE4H41izaFqMn3j06EnpWnOmTyHmIguc4EbZPQkf41NHpcsjlrh+vU5yTXokfhqVv9fKB7AZq9baFbW7EhC7erc/lTdQtROI0/Q3faEQpH3Y9TXVWOmx2sYCJjA9OtbCW6oRtH41K8I4PXpgCo5i0igkGAW4yelBQkHPpV5ozt+Xk/SovL+bgc9aVyikUyBnp6U14wRx+VWnTPQY7UwqRx6c5p3Az5Iu3Gc9u9MaP5uMGtB1Gc9V6VAY+Dg9/SmBRZccEVE8Y28etXZVwDlc4qNo2JBGMGmBSdMHg5x14quVPJIB/lWi6cHv2NV2jO7GMelAIqKp6djSOmCcGrRXaD3qM5x0APv3ouMoygkdOhqLBq66cZHX2qLC+h/WmB9Cso69aAg5A6n3qQpx75pu3Bz6da8850yNgSMds9aTaxHXj3qVhjpkj6UKAp7e+TTuO5Gw2fMOp7UqKT9T2ocjgEdakC570C6ETKCQD9BUaxkngYH86s7Ny8DnNOK8++M0XHciXgcd+maiaMFBVh1IUZHvTABjPIz2pAn1KpUNyR3pNhHoR71YKg5IIyTgUYbpt5FM0uVdh4wDmgJl+AMe55qy4HOOvSmiIkDA5PHSi4XuMCAZ2n86RgODxjqakAOcDrTMYyD/AI0gEVAeSPwqGVQqnBBqz68D61B5WSCT8tMa3Mi8tnlkAXhetEcJjUAL0rWZMjGMUwL8xOMnPU1SZv7TSxAik4z1J70EZbkc+oqcptAOMfWmBdwJPHNO5kyPGARgE9jUbgngjgfnVkpkgY4HNDrwA/X3oTJKRUk554poDZzkbR0q464QAfWonXcAM07hcqvn3qKQnnqAeKtug3DPUcVC8bbOfqTTuCsUXQlxgAVGwJxxwKvvGCNxPzVXkT5mIxx2p3K0Kph3DpioXUgDHJzV6RRgEZyRzUHlYkJPOetMpLuQqpwckfWlKKWXAyCKnKnaFUAk1GAMe+OKdxNEDwgAmoJoyAQeRVoqQMnJprqwzxyKq5NjP8tipxxjimmNu/p3q2qjODj/ABpxULHkgdM5NO4My5YyT1+tROuPwrQZQzHg47VTeMnNUmCKzpkHGKilVQTjdwBirBXBJzUbIfmI/SncdirIvGQOKjUZYE1aeIlOevtUKwncxPTtikV0Kzr1A6dvaofLf/Jq864Q54NVdg/u/qaaZJ9CLjZ8vWkZcLjGP609emfWgt8/TgVwHOiAoTk8daNpDcdKnOMjgAUjdO5FArlYKwbd/kU4EgZqVFJJzwD2pQowaAuMjbceMdO1OfPBHbrSIvcU/G7A6j60MrZjFGSc5I7Zpjr8m0Yye+KsiMjpUTg8c4FIEyDyyCCRxSKuWG7g1KGwuBnmkK4AOSTjtTKG7Bz09yaaACQ3H5VMwDcL0AoYfKcZH4UAQPGc9sn86aU2tkkYqyoUoOue/vSEADtzQO5UZWIx03c4p20cAnnpUrcYLdqaRsO4DGeOe1MCvOyxnrSFSTzx9KJ7dZHRiDlTkCrXl5HHHegq6SViqsZxnJyO9NkXjFWyhJGOgprxjHvnGadxc3crKMfeI9fTFMmGehFT7O+cZqJxzgcgfzoGkVyRnO3OPWmjp0qR0JOAcY6Um3hQBhs+vWqKI3j/AIhzxUMowMAHFWSCTjoaRkGBjj60yTOlAzj2zUb/ADdBgn9K0JIwTyBuHQ1X8va/PWmWrFbyy6nHXHFMEWGUNn8e9XTwBxmq7kkkHr1+lMFdhJHjAAAx0qsUwe2akkiLyRsXYY5wOM8U4jmmJaFUpxgD9KhdCOg61eK5fNMmwoJYEjoKodykELfUcVDKCRgdDxirbAjgcCoCuc46dqYioyDo2f5ZqN4x2xVuVNuOpPfjpULBg3PB9qYMpugI5HA96hZRnhatFSfvD8aRowqEjr61QnoUyvTpk1DIcKcDI9hVg8//AFqjcbB3/Cgq1ilNhuRVLY/r+tackYOWBx3+tV8yf3F/OmgPoPbjkjpTGTJ3e9SkcAjmm47MOK8840yJwAOAeaYq4Bxn61Myk9uaFXAxxTuO+hHkDj8qQgZ46ChhyR04p23p3zQMRVAyQBTxgN0GetJgepxQ/AAPWkG4rEMCPXvULKVPPOKkC8ZGOaHJxgcnrx3oQ1oVweCPfNOIOcCnIvIz27inouEwQcdaCmyPBBAyPrTCcHGKsEDPUFh+lMZTxzz9KATI8beD+lHqD6dxUmM8HBOaOGc5A9KB3IyPu5NMkHJC/d7VOFBJyPxphTnqME0AmRLEDyc5HvUh5wPTvTtny4OcH0oyFxn0phcjxgEYpHGVH8qVm7+lMPzIcnAzx7UFbkJHXPFMCqrEkcHjGatEA5JA6ZqEY5z+dUmCZH5f4+maZtXPPX1PSps4GCO/FMdfl5/OgZX24BPUZ6mmSElR7VK4IXHHJ4qPBZcHHFUFiLbufB4JqCRFRsEEt6CrZyi8H5s/lTAQX55NMogZf3XPUVDMoZC/c1bYDPHA71CUbO4rkZxTBaEQjwQRmoiAGOOOOasvxjgjioCMthuvrTQLUgkBDYHSomHy+wqZssSv5YphU8n17etUUQtF8vAwT+tRhRn/AOtVkJu2gHB9fSo2XCE9+2KZJUm45OO1QTHBGQankRipP3vrUDjJyQcD0NUh2KrjcgHfmk+b+4fX61KyjDnpjFN3ArntTEyky4c47GmMpIwoyc1Idxmb6U1yyMX5GR19KC2VnXA+Y8Dio/KHv/3zU8oG0n1Haq3mH1aqRJ9AAYWkA4znP9Kk4AHOSeBTDlG6c155xoTPzY7mkYjjr6Un33PUfQU442/1poGhpHzcj2ppzgd19M0qNv8Arn0qRlxz3oDYgGDnjrSgZwO9OC5cmgru3A4IoKuDfd+U0gQrtIPJ9akVTwo/WhxgHjmkJETJwc9RjPFGM4HtUgU7eeTnJ5py4Ynp070FEIHQDoRzTSMngcn1qdsFcAe1N27Rxjj1oGiALgtu79eaM7cHrj1qVxnGR97pTCgwOmPSgZGGb5uPwpApOMHIHtUzIQQaQjjj+dAegzDEYBpsgyp5O4d6V8hecjntTJTyPTv7U7DRH95cDNNC/Nkj5ac/YDOacowgBpl3ADHc1DIvB9On0qcPtHPT6UyUNtyo/wDr0Ikr4ycZwevNNZWII/KnqDgA9cc0NkEg5qiiMIccnIHpUbR5UbcD61LuVeKjD4bPOBTQakEnPBzn3pEVcnJ9hipjjJ6c9zTANuRjH1pjuRMvII6Chhz2BPpUjHqG7Hp7UrjgeuOaAuVNmT8wOPXPWo9uTkcH2qxMd2OduOahHI649cd6pDIZE+buDjFRPH6gAj171Z6cj0qLHKnH69KYEDArj86jZMrjvnNTvwWwOKYxwSD0qrAVWHHQioJgMZPftVifhjnt6VWnJCEjPTFNDSKrY+7gfWojGwJyeAean2rnKnPY1CzgMwwcepqkNkMwVAMflUMmBjP4VYfdk7j8pqGdckFetA0U5Yg0pbqOhGaj8tP71WyCWOFqPJ9B+VNCZ70oG1eKTAJGe3HFNUHk5zz6dKfgNyTgd89q8+5xERwoJGGzSFvkI4Ue1SHDKQR3zn0pknABA4HX607gRqcZweQaeRnA60w7SwXr9KU53jjj0oGKeOucHFGSceh96aW+bAzzxTUB29KBolUjr3+tDcqTn86Rs446e1NI2YGeP5UDsKR0IAz3pc5bAoztHJJHWmoeTlSM85pDQ5ieg5/Gm4JPzDg9aVPvZbv09xSscYA6flQA1+CAB7803krjP51Iy/Lz60gAGAetA0xhPQA/WmquSAeD6U7aTnAp4H1oBkLcED16VBsyxKnirEigp3zn86roGVRnNUikIELNtA6dPejOCQetPALNnOKjkVskk44zzTHuGMDrz6U2TIHtShMrgHOf0piR43AnPp3oGR4OAOWwe1RkFnA6H1FTgENhefX0pkikEEYx7VQXIcdfemE7clRnvmrBBKkLjkg1Ey7sk8AimNMgRc53DBz+ftS5+fnlR0pGO1zkHb0py5Gc4z2NAMTaWcdcYpjHcQSeaXdwQBjH60zBXk8e1NANbABycDtUexQwHBwetSZycE9ORmm7WCknBINMZHLxnnjrUUmdvAA+lSykH5PQ56U3YA4A6CqFsQOo5UDtmoHwBkH5h19DVmZCQMHGOtVSThhjOe5poaKshO7B6dahyWOMfSrMqkt0IzUBQqzYbJz2qkUV2C+YxUAAHj0qCRNxbnJzmrew4GBnuaiPBPHHWmhFQjaVBGR+tRvnBxippuSNucjtVdlyepH0NMaGE55PB9aj+f0/Shiykg8A9xSbv9o1SA9zTd0ByD0BNSK2F5zmmRvtByMehpX5UZwBXnnEhjsDyCc+lNJzkZIA68dKdztAAGPzpij5jvBGRgYplDE3Z4HNSruP+e1R5xyBxQnJGDkHjFAx+Mk5HNM3N26YHNDcseR1xSYJI7HqM0ATjAU57Gmv64HWhDkEYyM84ofGDk49KTBCD7x3ZB9aUhcjkYpgbBAHOaVhuIx0x2FBQ9W56cU1mAYD09KUDAIx9DShQGyOaAH9ueh60BR8vGeefb3pqj5j1AoJ6+1BI5Tg9KYxz1PT0p2V8s5B60zrjk59qQ0NJwSCAM9qjbGTkH8qeXDMSeQPbFNYZUn060yrjCpwATx7dKjlORjt0/8A1VKQQ2FPUZ5pjgDBGQTz9KpAiJ3AUd8dgKRcEE+p6UMM/N1HTp0p5XCleQfcf0oKIiOM7cE8cVEQUHzHp0zUv3nII+YcAHpUcrElc4575/WqQyMynBOCT+tVbpmUE5JXpmrUu0DBzx3FZtwXLfL93HTpTRdNXYBw0h3ntn61YiYMh5/OufiL+dIjclG4Oa3IGAXPQgj/AOvVNGlWHKPzt5JBA9e9OChl29+uT2qMnBIJBB9KAxUDnHrj0pGIuzL55PbOM4pw+VW5GCKARt5zkjpTEcD5eORgDHFMGQPtySw+uKZgDKnqe59Klb5txwM9+PSo1YqNxwcc4HpVDZG+Cx9uBVMg7/8AZ/nVuUqW7AAd6qhh83A9aaBEcoLnGeQKryKCwxx3qzMy9R1brUEzAkEHjPBqgRXOVbIAGfWonxg8flTnI3ZHU1EWIXAwaZRBN8qqQeRURjzyDU8g35A6jkCmyYCLnsaYO5SkU7xj/wDVTvtDf3U/KknY9yNvXk1U3L/f/nTQ/U93iYFvUAUoA3cnC9sVChHIHQmnFh07ngiuA47D5CFGF6/zppJG0Lxn+VJ8r4HQ0x2IUqW2k00CEZuOMYpA+GAB6dxVeSU4zgYzUqZJ47dadi+WyJn+YZBx708EY7H6CoATgDp9DUqk5wDx+HFImw5fl6e1Pds5UDPH1qNwOWIwfXNOAwFyBnvg0gGYwx561OuDjvUbqCMHr14pY+pJOO1A2LJxnd25pEGG578cCnjnJx370AFW+YD/AD60BcMcj6AZ9qUDHTrSMzdeM+op4YZPTnJApXERjHzYx0qMMevQHqMVIcbT6j0pr4OWxyO9MaGuuAMnJ9aYBhy3U049cjJzzinEoO2fWhAROAWGS20VG4ITtj1qSRvnyCP5HNRSOf4iDnpTRSI2JCjAJ56UkhwjHnOKVjgE+g6E1GwO4g5II4BNOxSEdOMjO4gH3qJn3E/KDjoDSk5znGR7f1qJpNrjP8XJ461RS1Ekk2nHbpVO5JYNjg9OnerEzjG4KOucVWYjOcbgeAPami46FCOEJNvI5GSfU1pxnKgnBQjpVUADAYYz1FToV5544qmOcrjgyu/yjvnFB65JyGHemB1LuRn5eMdgaikY8Ag8HkDtSJSuSpIAwXOD0waUt0U4LAcMKzpZgz8vzjjParMJ3IhyMnJHaqsVKFtR5wdwwc9j+tJIF2AnrjqKAxK88HaTj3qEvjIP930pkMj3YDZGQP50wKpZiefUU4sNuR1z61GpwWGMsRj8KYyGTqRk5PSoJDghSTyKnmfgjtjmqzE7mI6DHPTFUhogKsxz1PYVFt3KfzqVpPnJz+VNbg5GPamhtkDE5yOhHeqUryu5AjZWPBz0/D1q9IVGTwSOlV5WJOfT9PWgEUgSJQccjqSKKfNz84/Gotx/ummNntZdd/ynAJJwKcGBIPvwKqh8R9DxyfX/APVUiNgDd0x171xWOSxMWyDt4GOO9V5WwvUYx3p5YZ4Ocdqo6izLG5zwe4FNIuEbuwizo52Ag4OfpV6M4jGAMd81g2kYMmUVhxyTnk+tbUL8bWYkj8qpo1qxUdEWByQFA/Cpl6H5h0/OoYVC4B6e5qdcenPpUnM2JkbcsD9OtNDCNuSOeh9aUOxyABg9SO9MkJZv9oDvSAlyMAO2c85FKuNwYcDBwBUA5T5sDPpT1YgfN160DLCkgHnk9vSlY5IBIGagEhOCQzAcj3+tJnczZ+90A9aQrEwVcH3zS5UYwfmx6VEoPBLDI9acXUbufmPSgBWPQjpnp60xf9YDuJGOgpfMDY7n1AqNiNwA4JBoGKx+dByT3I9RSM5DAhvqMZxUTH94FLfePQ0124YNx6etMqwrOSPmHI4B9qjZugBXjsKTeCRnqMcE1HLJ82FGee+MVVikhsjBQwOQM4HtUDP8jEn8/wCZpzNvA3DKg+vJqrKxxgDGe9Ui0ibzMRHJOaj3DdjJwOeT0qtJIVRjuyOwHJqGFyCxZwcjgelOxXL1LEjZyQSM9/aoXcBWPTA4x3prOpZcckjNRtKPKD/gKqwyRG42/mf8KVyAqjIYkdjVXeeGORgUM/zAfw55+lFge5YJJUYPJOaq3Nw/zMr9Tjk9ulOkfeScjdjOAapz/cx6jPFNIunvqV5pV+0qVOR+eavx5U4J4xweuKyPJIl55x3rTRtiMSQQD0qjSq10LJkO0YzuJ5PYe1NaUFTyCSeoqBZMhSRkHgCoWYZ29CATx2osc9icuFfr7g5prSE53HkZ4xVYNkkjHsDTHlxwckjqaoLEzuN3X2I9KhZv3ZzjOevce1QO+CzMfwqI3HyqC2BTQWHs6qBnJA6ZP61G74U5XkfpUSScneCQDjnvTbpuOCcYpgNDEEtxnNNdmdVBGCO44NQFxtppcMvJPpzQUOkOTlTjPWqmF/vH8qe7hkwcH6Uzef8AOaBXPY1kGQB0HLCnq+3B+bJ456YrOikAJOTgnnvipBOc8tyeMZrksYWLkjYBUHoOpqKSRZG+bHTAJNV3cvjAGfc0122nHX3ppFLQmjCxgFc4HOBVsMC3UciqCytkgkZ9PahZCBxgqDxxQ0D1NTcu4beRn1oMh3AbsjqPeqaTchVIJPAHSleb5WAJAJwCKmxnYvq5Hct349KZ5wyAcBiOgqukuVGCQc/nSZTaSH45/SiwJWLkUjFABxz0POadLIWBGQGxjOORVDzgoX5z0HC1JHKZFUN8uRnaODRYLdS0jAgnd9c/rQ8gYEZGR2NUlYE8HJwT9aUyYYMTjvx2osFi4ZVXPBwTxUYk3uSHGRwQar+d8hIJ59fWmK6kOSwBIyaLFJaF4Sbl4Pvj1oZxv5HAPPNUUlIiHA6E0NKpcEk/lSsKxbkICZOCQOp6/WoJZQ6EL1PcH0qC4lIGSPwz2qtJM6yCRjkDnBPFNIuKLbyshOAM4H0qJnJ+7ySOTmqklwVBO4E9iO1QvPt4HB65PbmqUS1EuGT911+6cdaryzYYjIJI7cVX88qvysMZx+P+FVJ5e7bsZ4x1qrFRjqTyTjBHXv1qr5wDsBjpmq7S4XacZJzzTJWUSDnIxzVJF2LqTqp5OcZxTTKCg578D1rOkmBcFSc56UolDDGcDrzTsFrF8NhSpOAB1zTfNBUsT+Jqj5pbBycZwaBOAp/u+tBNi60vJK43Edaglnyc5xjvVYzBcZ7nFRySdB2zmnYpaFlHG49BmhJRIW2nIA6iqQcbAW3dcAA9aWKYIOMD1p2G2XwwK8djkYqGWT5mbj6VWeUcYPU5NRvKp5ZuR/KnYzJgWbgsOvWmGRW3ZOAf1qCWXCkKf6VXWYhmz0PrTSC9y1LLy2RkDnmoGl4GMA/rUE0gJJJ9hUbTBCNwyelUJFlz1y2cdPrUEtwTn2qESkNk9OeKheToRjrQBO8uHyCORTC3Izx2qu78dfypvncYbg4pWGSs5BwME9Mim+afSqjS8kqMA8/jUXmH+8fzp2A9gilwgJwdvBJ4/GlVmxuYfKTgYrJS4U4GM5Hc+1S/aVjG7jn16VhymdjV80fPnjAwOOlNL5BBIx1yO9ZazE7SGHOCfWlE/wC7ODxjgZ/rRyisaIkHGWII/HIpTNkrtON3X3rM+0FQX454wO1RG5O3qT7CjlKSNY3O1TjB9OOhqV7jAKNyR0Oaw3ufkclsd6gtLwu47qTjJ7GjlNFC6udMl1lA5bOP4SOvvUnnEsANw3ZyRWElwY8ozdBgYPTNSi5GSFZemaOUycTRaYBjgkYOMn+dKtweitnIwSecmsqW5yqqM56k8VJHP8g2OSVPT8fWjlBrQ147jYMsQPcUPJycgDHGRWYZsEdDnqc9KY1ypIDFjxgFf0pcpNjUlnQIjBuCQRnrUTz7WQswbd+VZryqFX1zyD/KoWuMnk528cf0o5S0jUF4A+clwoIBPrSrdkyEDp6fnWM0x2AA9eevGfejziD8vX0p8o7I2ZJwyFR0HB56+1RTTbi2WBUYzjvWW0w3k7gAaDcBFbJ5J780co0i28+AMEgk9B25qB5sjBbOTjA7VS8/cynPC9qgmnOScgrnrVWKRfMmVIUnnsKiklBGM5bGd3pVFrkFTjIH61Xln24KgdRT5Rlm4mGxRuPzH+tRNPlQS3GMHNUWlJHHXruqKSbgJkcelOxVy+s+ASTnJpZJQQBu69zWW0ygAD279KDKSetOwrmkZiQQTnPHpTBMQpA6DpVJp+MNSNMMUWFc0VmOAcjApHm3Oc9Kzmm+b5en9aQz+lBJeM2cjnAPXNMM/wAxLEA1RE+QMHvTZJcHGRnGKYy6bnJGDgUwzgL1zmqJl9KiabB5b8BQgNLzh36mmO2Op5z0rPWekebIznH0pkMtSTZc9CM+lMkkBXHHrVJpfmB9KaJhgjkntTAstIPXmomkIB6HPUiq8kxBOMgn8qiaQH6ZoAtmTLA9KZJLnBYj2qqZDt6imbzjFAXJfMO0880zcfU1A8gxwRmo959T+dCQXPSxdYCg/MuO/NOEpYkMM57Zrnorndtzxgc89an+1EHIIP8AnrUuJJuJdBXGf0pXuAJAQeDjI9KwpLvbtPvQbnBB/HNHKBtySnryVHv1qNbgAttbAIHP+FZQuCwx0wegpFcFQFPA/SjlGnY10uOCSSR0Az096aJtoLAZ+lZLXHPGM5796UXGTkHHbFFh8xsfa1Ck8c8mnG6Ayy/n61i+dkH5gRTvP+Ug8nOPWjlA2kuiW6gADHPan/aAq4B+YjmsH7TtBCjnpTxeF23M3Pr3pcojoTc7WznGARgD1qsbvaxI4GePesU3h2gBs0v2ncgBwPTmjlElY2ftGGzI/wAoIBxUTXQXcSTgAsc9hisczggAHIo8/g/N0osUaouxtzjjHHao/tDc5bkc5rMM+R8x4xSPN+7LZ5p2Hc0zeNjII9KPtBIIB7/nmscXDbACQKa8+0HBP1pWGaxm469feojLjJJGTwKzTNlun1ppuB0J9+ewp2AvvOSoA4OKgmmI/iJGPyqhJcEsDnimmcEDPB74osBZkmPTd261B5/IPp3qs8uWIJx6ZqLeM9SR6miwy6JhuJPTNKJupLd+KzzIetAlI5osFzRMqkDDH3pTMMEk5HTj1rN84+go808f5zRYRf8AOBJwf/r0jy8nOeB+tUTL2A+lNaQnvRYC6JWUk7gcdKY8/wB7njpiqZlwMe1MLjFOwrlsT4Oc8elNMnOM4qsW45PNN3j14x1piuWGlPbH1pGkB6ZzVQyYbjkUzzD9KAuXGkJ9cU3zSeM1VLH14FIXJJ5oFcsPL6nP41H5vHA/Cq5k+bGR9aYZRwPzoEWfMPOKY7k855HTmq7Snn0qJn6nvQIsvKBjBzUXmH/JNQCQY61Hvb1/SmkB1UU2CdhGasLOORk4rHR2DcHpUoZj3o3Fe5qickYBOfSlE+QCOcd6zlY/L75pokb1oGjUM5UqCTj260pny2OM+hrLDEy498U+VioBFIZoPOc4LdOgoWfC57elZquzEZPU0odg2M8E4oGaBuDwMcnmlNwcAZOc5JrPZjj6Z/nQGJBPpSGXjLhvvcDtmgzlt2TgYqirk7ifrUZduuaA3NEXGGHPJ5p3ngg4YH+lZjsd2e+KTcSOewoA1POxnJxmmvcHJANZrO2epo3NjOTSBGgLj5uTSPOdx5yM1n7jnrSbjTC5omfCfexUTTerZqmWOKYHbfigaZe+0YIIyQKb52eSDmqhc7WPocU1nYKvPWgLlsyfKPrUZl+br71ULn1pCxORmgC20gJ5NMLjBIqsSaTcfWlcVycSdRn86PN49arAnNCkkZouFywZT2PNOEwwaqbjuIpVNAXJzKc570hlP5VA7FVyKY7Eg/hRcL3LBkJphfHOar7j/WkLHNAicPxk8c0u4ZwDzVbJ9aQscge9MRayOuRiml1GKgJzTVOVBoAmMnqfypm8jI9e9RSMR0qPcWGSelAidm5zTHcAe9QFiRTWOMY9adgsSebk8n6Co3fqc9aiViWAzwTTMk1SiMeZTjFR5P8Ak1HISDwTTNzeprRRA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Approximately 50 percent of patients with Ross River virus infection present with a rash consisting of scattered, 1 to 5 mm, discrete maculopapular lesions on the limbs and trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Richards, MB, BS, FRACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43854=[""].join("\n");
var outline_f42_52_43854=null;
var title_f42_52_43855="Clitoromegaly2";
var content_f42_52_43855=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76693&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76693&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clitoromegaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 390px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Clitoral enlargement in an infant with a 46,XX karyotype.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Clark DA. Atlas of Neonatology - A companion to Disease of the Newborn, 1st ed. WB Saunders Co., Philadelphia 2000. Copyright &copy; 2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_52_43855=[""].join("\n");
var outline_f42_52_43855=null;
